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Abstract  
Plasmodium falciparum is the causative agent of the most severe form of malaria and continues 
to pose challenges to international healthcare, with high mortality rates and emergence of drug-
resistant strains. Plasmodium falciparum has multiple sexual and asexual lifecycle stages within 
its Anopheline mosquito and human hosts, accompanied by distinct morphological changes. The 
complex lifecycle, along with the ability to adjust rapidly to different environmental niches, is 
governed by highly regulated and tightly synchronised changes in stage-specific gene 
expression. In eukaryotes, regulation of RNA Polymerase II transcription initiation is one of the 
main mechanism of gene expression control. Past research has revealed the presence of crucial 
elements of RNA Polymerase II (RNAPII) transcription machinery in P. falciparum, however, 
the precise transcription initiation mechanisms in P. falciparum remain to date undescribed. 
Bioinformatics studies have found very little homology between human and P. falciparum 
transcription factors. Furthermore, because of the extreme bias toward A/T in the Plasmodium 
genome, TATA-box and other core promoter elements that direct transcription initiation, cannot 
be determined with confidence in bioinformatics studies. Functional characterisation of the key 
protein factors involved in transcription initiation is a first important step towards the 
identification of core promoter elements and could reveal currently unknown eukaryotic 
transcription initiation mechanisms or new anti-malarial targets. In eukaryotes, TATA-binding 
protein (TBP) and transcription factor IIB (TFIIB) are the key protein factors involved in the 
core promoter recognition and RNAPII pre-initiation complex (PIC) assembly. TBP nucleates 
PIC assembly by binding the TATA box, thereafter the TBP-TATA complex is further stabilised 
by TFIIB. In addition, TFIIB has a crucial role in RNAPII recruitment and transcription start site 
selection and is therefore deemed indispensable in eukaryotic transcription. P. falciparum TBP is 
the only PIC component in P. falciparum that has been functionally characterised to date, albeit 
to a very limited extent. This research study reports the successful expression and purification, as 
well as initial characterisation of DNA-binding activity of P. falciparum TBP and TFIIB. We 
observe PfTBP binding at multiple locations on putative P. falciparum promoters. We further 
report PfTBP-independent binding activity of PfTFIIB, that has not been previously observed 
under the conditions and has implications for novel DNA-binding mechanisms of PfTFIIB. 
Furthermore, we conclusively demonstrate the formation of a PfTBP-PfTFIIB-promoter ternary 
complex. 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1. Introduction 
 
1.1. The impact of malaria 
Malaria is the leading cause of morbidity and mortality worldwide, and continues to pose 
challenges to international healthcare with the recent emergence of drug-resistant strains. 
Currently, over 40% of the world’s population is at risk of contracting malaria, with over 200 
million cases of infection and over 400 000 reported deaths reported in 2015 (World Malaria 
Report 2015, World Health Organisation 2015). 90% of malaria infections and deaths occur in 
the African region, with malaria remaining one of the leading causes of child mortality in sub-
Saharan Africa. Malaria is caused by parasitic protozoans of the genus Plasmodium and 
transmitted to humans by Anopheles mosquitoes. Four species of Plasmodium cause malaria in 
humans, including P. vivax, P. ovale, P. malariae and P. falciparum. The most severe disease 
progression and the highest mortality rates are caused by P. falciparum. 
1.2. Plasmodium falciparum
1.2.1. Life cycle of P. falciparum 
P. falciparum is an obligatory parasite belonging to the phylum Apicomplexa. Most 
Apicomplexa have a complex lifecycle with sexual and asexual stages in multiple hosts. P. 
falciparum parasitism is limited exclusively to its human and female Anopheles mosquito hosts. 
Transmission to humans begins with a bite from an infected female Anopheles mosquito, 
whereby sporozoites from the mosquito salivary glands are released to the bloodstream. 
Sporozoites rapidly invade the liver cells (hepatocytes), commencing the exo-erythrocytic cycle. 
In hepatocytes, sporozoites differentiate into trophozoites, which form schizonts by nuclear 
division into many small nuclei. The multinucleated schizonts undergo multiple fission to form 
merozoites. Merozoites are passed into the bloodstream, where they access red blood cells 
(erythrocytes; RBCs), marking the beginning of the asexual intra-erythrocytic stage of the 
parasite (Cowman and Crabb, 2006). Merozoite invasion of erythrocytes in an essential step in 
the parasite’s life cycle and the erythrocytic cycle is the only stage with manifestation of clinical                        
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Figure 1. Life cycle of P. falciparum.  
Schematic of the life cycle stages of P. falciparum. Illustration adapted from Cowman et al. 
(2012). 
symptoms of disease in the human host. In erythrocytes, the parasite development continues 
through ring, trophozoite and schizont stages, producing a large number of merozoites that are 
subsequently released, which proceed to invade other erythrocytes to continue the asexual life 
cycle (Cowman and Crabb, 2006). Merozoite release from the iRBCs corresponds to intermittent 
onset of fever (paroxysms) associated with malaria. During the 48-hour intra-erythrocytic cycle, 
parasite population in the host drastically increases, with up to 50% of RBCs infected upon 
maximal P. falciparum parasitemia. 
During the erythrocytic stage, some merozoites develop into male or female gametocytes, that 
are taken up by a mosquito during the blood meal and thus complete the infectious cycle (Alano, 
2007). In the mosquito, the sexual sporogenic cycle of the parasite begins with the formation of 
zygotes that develop into a mobile ookinete which can traverse through the gut wall to form an 
oocyst. Sporozoites are released upon the rupture of the oocyst and migrate to the salivary gland 
of the mosquito for the subsequent infection of humans.  
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1.2.2. Pathophysiology of P. falciparum 
 
P. falciparum infection induces the most severe progression of malaria due to distinct differences 
in its biology compared to other Plasmodium species. P. falciparum has developed multiple red 
blood cell invasion mechanisms and utilises antigenic variation, making it capable of invading a 
large population of RBCs and evading the host immune system (Miller et al., 2002). A key 
determinant of the pathophysiology of the parasite is the ability to alter the properties of the 
infected red blood cells (iRBCs), which as a result adhere to endothelial and other intravascular 
cells in a process termed cytoadherence. Cytoadherence of the iRBCs is caused by parasite 
encoded proteins that are presented on the erythrocytic membrane and interact with the 
surrounding cells. P. falciparum systematically alters the epitopes that are exposed to the host 
immune system, in effect avoiding detection by antibodies and thus ensuring persistent infection 
(Kirkman and Deitsch, 2012). The primary P. falciparum antigen is P. falciparum erythrocyte 
membrane protein one (PfEMP1), which associates with the erythrocyte membrane proteins via 
P. falciparum knob-associated histidine-rich protein (KAHRP). PfEMP1 is expressed in highly 
variable forms by the var gene family (Baruch et al., 1995). P. falciparum genome harbours 
approximately 60 var genes, with only one PfEMP1 variant expressed at a time (Scherf et al., 
2008). Switching the expression of var genes at low frequencies results in antigenically distinct 
populations of the parasite, which minimises comprehensive immune recognition by the host and 
ensures persistent infection (Miller et al., 2002). The adhesion of iRBCs to uninfected RBCs and 
endothelial cells within various organs excludes iRBCs from systemic circulation allowing the 
parasite to avoid clearance by the spleen. Many PfEMP1 adhesion domains are common among 
PfEMP1 variants, whereas some variants have specialised to bind host cell receptors within 
specific organs, such as the placenta or the brain (Fried and Duffy, 1996, Montgomery et al., 
2007). Parasite sequestration within vital organs results in serious physiological complications 
for the human host (Kirkman and Deitsch, 2012). 
Highly coordinated and tightly regulated gene expression is a fundamental aspect of the complex 
life cycle of P. falciparum and its sophisticated host immune evasion mechanism. Consequently, 
understanding the precise mechanisms governing P. falciparum gene regulation is an important 
prerequisite to fully understand P. falciparum biology and pathogenesis. 
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1.2.3. The genome and gene expression of P. falciparum  
The P. falciparum genome is unique in its adenine and thymine nucleotide (A/T) content, 
accounting for more than 80% of the genome. This extremely A/T-rich genome is unparalleled 
even within Plasmodium species, with the P. falciparum genome being the most A/T-rich 
genome sequenced to date (Gardner et al., 2002). Out of the ~5300 proteins encoded by the 
genome, 60% remain without a functional assignment due to little or no sequence similarity with 
other eukaryotes. 
Past research has provided evidence for control of gene expression regulation in P. falciparum at 
transcription initiation and post-transcriptional levels, as well as via epigenetic regulation 
mechanisms such as chromatin remodelling and histone modifications (reviewed in Horrocks et 
al., 2009). It is likely that a dynamic interplay between multiple levels of gene expression 
regulation facilitates temporal gene expression in the complex life cycle of the parasite.  
Seminal studies into the control of gene regulation on the level of transcription initiation 
revealed that key eukaryotic features for the transcription regulation of protein-encoding genes 
are in fact present in P. falciparum (Lanzer, 1992a, Lanzer, 1992b). In eukaryotes, a bipartite 
promoter provides a platform for the assembly and regulation of the RNA Polymerase II 
(RNAPII) transcription machinery. General transcription factors (GTFs) and RNAPII assemble 
at the core promoter region, forming a pre-initiation complex (PIC; Figure 2). Regulatory 
regions of the promoter, termed cis-acting elements, are located typically upstream of the core 
promoter and associate with specific trans-acting transcription factors (TFs). These sequence-
specific TFs can stimulate or repress the transcriptional activity of RNAPII through regulation of 
PIC assembly and/or function.  
!4
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Figure 2. Eukaryotic bipartite promoter 
Simplified schematic of the eukaryotic bipartite promoter comprised of regulatory DNA regions 
(distal and proximal promoter), containing cis-acting elements and the core promoter, containing 
core promoter elements. General transcription factors (GTFs) bind to core promoter elements, 
such as the TATA box (recognised by TBP) and BREs (BREu and BREd recognised by TFIIB), 
to form a pre-initiation complex (PIC) with RNAPII. DNA-binding transcription factors (trans-
acting factors) bind to cis-acting elements to regulate PIC assembly and function. TSS, 
transcription start site (+1).  
In P. falciparum, association of nuclear trans-acting factors with promoter elements upstream 
from mapped transcription start sites (TSSs) has been shown to correlate with promoter activity 
and mRNA accumulation (Crabb and Cowman, 1996, Horrocks et al., 2009). Prior to the 
sequencing of the P. falciparum genome, the largest subunit of RNAPII (Li et al., 1989) and a 
putative orthologue of TATA-binding protein (TBP) - a central component of PIC assembly - 
were identified and cloned (McAndrew et al., 1993). Further bioinformatics studies utilising 
hidden Markov profile searching of the P. falciparum genome have identified the putative P. 
falciparum orthologues of the remaining, but not all, common eukaryotic PIC components. 
These include TBP- associated factors (TAFs) that complex with TBP, collectively referred to as 
transcription factor IID (TFIID), as well as P. falciparum orthologues for the transcription 
factors (TFII-) A, B, B-like, E, F, H and TBP-like (TLP). Interestingly, only three TAFs (1, 2 and 
7) have been identified, in comparison to 8-14 TAFs in eukaryotic model systems such as 
humans, yeast and Drosophila (Kokubo, 1994, Burley and Roeder, 1996). With the exception of 
TAF5, all the TAFs currently unidentified in P. falciparum share a conserved histone-fold 
domain that mediates specific TAF-TAF interactions within the TFIID complex in eukaryotes 
(Gangloff et al., 2001). In eukaryotes, TAFs 1,2 and 7 interact with TBP independent of other 
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TAFs (Chalkley and Verrijzer, 1999). Thus, it is likely that the P. falciparum TFIID functions in 
a more minimal form compared to other eukaryotes.  
 
Overall, a substantially smaller proportion of the P. falciparum genome is predicted to encode 
TFs compared to other eukaryotes (1.3% and 4-7%, respectively) (Coulson et al., 2004). The 
high divergence of the P. falciparum genome, exacerbated by the extremely high A/T-content, 
poses formidable challenges in bioinformatics analyses. Thus, inherent difficulties of in silico 
identification could, at least in part, account for the apparent paucity of P. falciparum TFs.  
To date, only a few of the P. falciparum putative proteins that are predicted to be involved in 
transcriptional regulation have been characterised in vitro or in vivo. A family of novel 
Apicomplexan - specific transcription factors, ApiAP2, have been characterised in vitro and 
shown to bind to specific DNA elements (reviewed in Painter et al., 2011). Five of the ApiAP2 
factors have also been characterised in vivo, demonstrating involvement in var gene silencing 
and sporozoite development, among other functions (De Silva et al., 2008, Yuda et al., 2010, 
Painter et al., 2011, Sinha et al., 2014). Two additional sequence-specific TFs, PfMyb1 and 
PREBP, have been partially characterised and appear to regulate a diverse set of genes 
modulating the cellular environment and cell cycle progression during the intra-erythrocytic 
cycle (Gissot, 2005, Komaki-Yasuda et al., 2013).  
With regards to the general transcription factors involved in PIC assembly, only the P. 
falciparum putative TBP orthologue has been studied thus far, with preliminary analysis 
reporting specific interactions between PfTBP and DNA sequences on putative P. falciparum 
promoters (Ruvalcaba-Salazar et al., 2005). Since the stepwise progression towards functional 
RNAPII PIC assembly is the principal target of transcription regulators in eukaryotes (Roeder, 
1998, Hahn and Young, 2011), functional characterisation of other P. falciparum GTFs involved 
in PIC assembly is crucial for understanding transcriptional regulation in the parasite. 
Importantly, considering the apparent evolutionary divergence between computationally 
identified P. falciparum PIC components and the eukaryotic counterparts (Callebaut et al., 2005, 
Bischoff and Vaquero, 2010), transcription initiation mechanisms in P. falciparum could 
significantly differ from that of the well-characterised eukaryotic model organisms. Revelation 
of differences in crucial PIC components between P. falciparum and humans could provide new 
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candidates for anti-malarial drug targets.  
Identification of the core promoter elements and cis-acting regulatory elements in this extremely 
A/T- rich genome has been equally challenging. Transcription start sites (TSS) in P. falciparum 
are to date poorly defined (Wakaguri et al., 2009), which further complicates the identification of 
candidate promoters and regulatory elements in silico. Despite numerous cis-regulatory elements 
reported by in silico studies, the identity of these sequences remains unclear due to prevailing 
inconsistencies between various in silico approaches (Gunasekera, 2007, Young et al., 2008, 
Horrocks et al., 2009). 
1.2.4. RNA Polymerase II pre-inititation complex  
 
  
The first step to PIC assembly is TFIID binding to the core promoter. TFIID is a multiprotein 
complex, consisting of TBP and TAFs. TBP specifically recognises a consensus motif 
TATAWAAR (in metazoans), whereas TAFs interact with other core promoter elements, 
collectively conferring TFIID the ability to bind TATA-containing as well as TATA-less 
promoters (Kim et al., 2005, reviewed in, Thomas and Chiang, 2006). TBP binding nucleates the 
stepwise  assembly  of  a  functional  PIC.  TBP binding is an induced fit mechanism, as TBP 
induces a severe bend in the promoter DNA upon binding (Kim et al., 1993, Nikolov et al., 
1995). TFIIA is then incorporated, enhancing TBP binding by competing with inhibitory proteins 
and disallowing TBP homodimerisation (Kokubo et al., 1998, Coleman et al., 1999). TFIIB 
decreases the dissociation of TBP from the promoter region, effectively enhancing TBP binding 
to TATA box by stabilisation the TBP-TATA complex (Imbalzano, 1994, Nikolov et al., 1995, 
Zhao and Herr, 2002). The TFIIB amino terminal domain recruits the RNAPII/TFIIF complex to 
the promoter and its carboxy-terminal domain exclusively interacts with TFIIB-recognition 
elements located upstream and downstream of the TATA-box, providing additional support for 
the TBP-TATA box complex (Nikolov et al., 1995, Lagrange et al., 1998, Deng and Roberts, 
2005). TFIIE and TFIIH are then recruited to the promoter and complete PIC assembly. GTFs 
are also involved in the subsequent interactions with regulatory factors, promoter melting and 
transcription start site (TSS) recognition (Hahn 2004; Thomas & Chiang 2006). 
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DNA sequences of the core promoter- including TATA box, the initiator (Inr), downstream 
promoter element (DPE), motif ten element (MTE) and downstream core element (DCE)- 
facilitate the PIC assembly, ensure its functional orientation and interact with TAFs (reviewed in 
Thomas & Chiang, 2006). The combination of core promoter elements differs between genes. 
TFIIB can make sequence-specific contacts with core promoter elements flanking the TATA-
box, termed upstream and downstream IIB recognition elements, BREu and BREd respectively. 
BREs stabilise the TBP-TFIIB-promoter complex by providing additional DNA contacts, but 
could also interact with (inhibitory) transcriptional regulators (e.g Mot1, NC2) (Chen and 
Manley, 2003, Deng and Roberts, 2005). 
TATA-binding protein (TBP)
The TATA-box binding subunit of TFIID, TBP, initiates the PIC assembly in eukaryotes. TBP 
consist of a phylogenetically conserved carboxyl- (C-) terminal domain and a highly divergent 
amino- (N-) terminal domain. The DNA-binding activity of TBP resides in the C-terminal core 
domain and is sufficient for PIC formation (Nikolov et al., 1995). The core domain is composed 
of ten antiparallel β-strands and four α-helices, that form a saddle-shaped molecule. TBP 
interacts with DNA via the β-strands located in the concave surface and with other transcription 
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Figure 3. Human TBP core domain binding to the TATA-motif. Tertiary structure of Homo 
sapiens TBP (HsTBP) interacting with the Ad2ML TATA motif (white) via 10 antiparallel β-
strands (teal) and four Phe residues (pink). The N- terminus (N) is indicated. Structural data 
retrieved from Protein Data Bank (PDB) entry 1CDW (Nikolov et al. 1996) and modelled 
using PyMOL. 
factors via the α-helices of the convex surface (Kim et al., 1993, Nikolov and Burley, 1994). 
TBP distorts and bends the DNA by inserting two phenylalanine (Phe) residues at the 5’ and 
3’end of the TATA box. Crystallographic studies have concluded that the structure of TBP-DNA 
complexes is highly similar between species despite of variations in TBP and DNA sequences 
(Patikoglou, 1999). 
The precise function of the N-terminal domain of TBP remains to be assigned. In the absence of 
an N-terminus, TBP DNA-binding and bending is enhanced (Horikoshi et al., 1990), the effect of 
transcriptional repressor NC2 is reduced (Goppelt and Meisterernst, 1996) and TBP is more 
likely to dimerise (Campbell, 2000). Wether these properties have a physiological relevance is 
yet to be determined. 
Comparative bioinformatics studies suggest that the characteristic saddle C-terminal DNA-
binding domain of TBP is conserved in P. falciparum TBP (PfTBP), despite low primary 
sequence homology to other eukaryotes (Buendía-Orozco, 2005). P. falciparum TBP has been 
studied previously by Ruvalcaba- Salazar et al. (2005). In this study, the binding activity of 
recombinantly expressed glutathione S-transferase- (GST-) tagged PfTBP on putative P. 
falciparum promoter regions are investigated using electrophoretic mobility shift assays 
(EMSAs) and DNAse I footprinting assays. The study reported specific PfTBP binding on 
TATA-like sequences located 81 and 186 bps upstream of the respective TSS on the tested 
promoters. The TSS in metazoa is typically located ~25-30bps downstream of the TBP-TATA 
nucleoprotein complex (Juven-Gershon and Kadonaga, 2010). The results of Ruvalcaba- Salazar 
et al. (2005) support a TSS selection mechanism similar to S. cerevisiae, where transcription 
initiation occurs ~50-120bps downstream of the TATA element (Zhang and Dietrich, 2005).  
Further biochemical studies on PfTBP have not been conducted to date.  
Transcription factor IIB (TFIIB)
TFIIB stabilises promoter- bound TBP through protein-protein contacts and interactions with 
DNA sequences flanking the TATA-box. In addition to its role in PIC assembly, biochemical and 
structural studies have shown a critical role of TFIIB in TSS selection, promoter escape and 
initial transcript stabilisation (Tran and Gralla, 2008, Kostrewa et al., 2009, Liu et al., 2010). 
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TFIIB comprises of four main structural domains. The stable C-terminal core domain (B-core) is 
composed of two cyclin-like repeats of 5 α-helices (Deng and Roberts, 2007). The aliphatic α-
helix situated between at the N-terminal side of the first direct repeat is termed the B-linker and 
stimulates the catalytic activity of RNAPII (Kostrewa et al., 2009). The N-terminal domain 
contains a zinc-finger domain (B- ribbon) (Chen et al., 2000), that interacts with RNAPII 
subunits and TFIIF (Bushnell et al., 2004, Chen and Hahn, 2004) and is conserved in eukaryotic 
and archaeal TFIIBs (Qureshi and Jackson, 1998, Gietl et al., 2014). Adjacent to B-ribbon is a a 
helix-loop structure termed B-reader that interacts with  RNAPII and is involved in TSS 
localisation (Kostrewa et al., 2009, Grunberg and Hahn, 2013).  
TFIIB is known to enhance TBP binding to the TATA motif by stabilising the bent TBP-TATA 
complex through direct interactions with the convex side of TBP (Zhao and Herr, 2002). Besides 
TFIIB-TBP interaction, first analysis of the crystal structure of the ternary complex of TBP and 
TFIIB core domains (TBPc and TFIIBc, respectively) with a TATA-consensus sequence, 
indicated that TFIIBc contacts the DNA major groove directly upstream, and the DNA minor 
groove directly downstream of the TATA motif (Nikolov et al., 1995). A consensus sequence 5’-
G/C-G/C-G/A-C-G-C-C-3’ was identified that interacts with TFIIB in a TBP-independent 
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Figure 4. Tertiary structure of human TFIIB core domain and N-terminal zinc ribbon. 
A. Homo sapiens TFIIB (HsTFIIB) C-terminal core domain consisting of two cyclin-like repeats 
of α-helices (pink), separated by a linker (indicated). The N-terminus (N) is indicated.  
B. HsTFIIB N-terminal zinc ribbon motif. β-strands are indicated by arrows (teal). The zinc 
(gray sphere) and cysteine/histidine residues that coordinate the ion are shown (pink). The N-
terminus (N) indicated.  
Structural data retrieved from Protein Data Bank (PDB) entry 1VOL (A; Nikolov et al. 1995) 
and 1DL6 (B; Chen et al., 2000) and modelled using PyMOL.
A B
manner (Lagrange et al., 1998). TFIIB contacts the BREu via a helix-turn-helix (HTH) motif, a 
trihelical bundle in the second direct repeat of the C-terminus (Lagrange et al., 1998). Further 
binding-site selection studies identified a downstream TFIIB recognition element (BREd), with a 
consensus sequence 5’︎-G/A-T-T/G/A-T/G-G/ T-T/G-T/G-3’ (Deng and Roberts, 2005). This 
interaction was only observed in the presence of TBP, indicating a the necessity for the severe 
bend in the DNA for BREd to become accessible to TFIIB (Lagrange et al., 1998, Deng and 
Roberts, 2005). BREu and BREd are found with similar prevalence in TATA-containing, as well 
as TATA-less promoters and the conservation of BREs between species is modest (Deng and 
Roberts, 2005, Gershenzon and Ioshikhes, 2005).  
TFIIB N-terminal interactions with RPB1, RPB2 and RPB9 subunits of RNAPII facilitate the 
recruitment RNAPII/TFIIF to the PIC (Bushnell et al., 2004, Chen and Hahn, 2004).  TFIIB is 
thought to allosterically reconfigure the RNAPII active site and thus stimulate its catalytic power 
(Tran and Gralla, 2008, Kostrewa et al., 2009). A number of studies have shown that mutations 
in the B-reader helix shift the TSS and mutations in the B-reader loop impair DNA opening 
around the TSS (Zhang et al.,  2002, Tran and Gralla, 2008). It is suggested, that the TSS is 
recognised at least partially by TFIIB through the identification of Inr motifs, whereas RNAPII 
itself might have affinity for initiation at particular sequences (Fishburn and Hahn, 2012).
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Figure 5. Comparison of human and P. falciparum TFIIB main structural features. 
The amino acid positions of secondary structures are indicated. PfTFIIB contains basic regions (+)  
spanning  amino  acids  1-37  (pI  11.8)  and  350-367  (pI  10.7).  Main  functional  interactions  of 
HsTFIIB domains are indicated. 
The TFIIB orthologue in P. falciparum has been identified (Bischoff and Vaquero, 2010), but 
remains to be functionally characterised. Previous analyses within our research group suggested 
a conservation of the main structural features of PfTFIIB compared to eukaryotic TFIIBs despite 
low amino-acid sequence identity (Steven Bing, MSc thesis 2015). However, some P. falciparum 
specific regions were identified, most notably a highly basic extreme N-terminal region, absent 
in other eukaryotes and Plasmodium  species.  The TBP-interaction surfaces of PfTFIIB were 
found to be reasonably conserved. The BREd-binding region in the C-terminal core domain was 
predicted to be reasonably conserved, whereas similarly to plants and fungi (Lagrange et al., 
1998), the HTH motif that contacts BREu was found to be largely absent (Steven Bing, MSc 
thesis 2015).  
1.3.  Objectives of this study 
Because of the extreme bias towards A/T base pairs in the P. falciparum genome, TATA-box and 
other core promoter elements that direct transcription initiation remain to be determined with 
confidence in bioinformatics studies. However, the identification of core promoter regions is a 
crucial first step towards studying transcription regulation. Our laboratory has begun to identify 
and to functionally characterise the key components of the P. falciparum transcription machinery 
responsible for core promoter recognition and PIC assembly. The objective is to examine the 
DNA-binding characteristics of GTFs in order to identify P. falciparum core promoter regions 
and the DNA elements directing transcription initiation complex assembly.  
In this MSc research work, I aim to investigate the function of TFIIB in the first stages of P. 
falciparum PIC assembly. This investigation includes the cloning and recombinant expression of 
PfTBP and PfTFIIB, and establishment of a high standard purification scheme to ensure high 
purity of the proteins of interest for DNA-binding assays. I aim to assess the potential DNA-
binding properties of PfTBP and PfTFIIB on putative P. falciparum as well as eukaryotic model 
promoters. Overall, this study aims to provide first insights into the DNA sequence determinants 
that direct PfTBP/PfTFIIB promoter binding.  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2. Materials and Methods 
2.1.  Molecular cloning techniques
Vector information
The plasmid vectors constructed in this study are derived from commercially available pET11d 
vectors (Novagen). Detailed plasmid maps of the final vector constructs can be found in 
Appendix A. pET11d-GST-6His-PfTLP and pET11d-6His-PfTBP vectors for cloning purposes 
were generously provided by Steven Bing and Dr. Thomas Oelgeschläger, respectively.  
 
Primer information
The primers used for cloning are outlined in Appendix B: Table 1. Relevant properties are 
indicated.  
Polymerase chain reaction (PCR)
In all instances, PCR reactions were performed using Kapa Taq polymerase in conjunction with 
buffer A (1.5mM Mg2+) (Kapa Biosystems) in a standard PCR protocol (Sambrook and Russell, 
2001), unless stated otherwise.  
The construction of pET11d-6His-PfTFIIB-GST included the generation of an intermediate 
vector, pET11d-6His-GST from a pre-existing pET11d-6His-PfTBP vector. Briefly, a GST ORF 
flanked by appropriate RE sites was amplified using two individual PCR fragments (amplified 
from pET11d-GST-6His-PfTLP vector using primers 1 & 2 and 3 & 4, see Table 2) in an overlap 
extension PCR with primers 5 & 6, as described previously (Heckman and Pease, 2007).  
 
The construction of pET11d-6His-PfTFIIB, 6His:PfTFIIB∆37 & 6His:PfTFIIB∆140 vectors 
included the amplification of PfTFIIB ORF from previously constructed pET11d-6His-PfTFIIB-
GST with respective primers (Appendix A: Table 1).  
 
Colony PCR for the identification of positive clones were performed as described by Sambrook 
and Russell (2001).  
 
PfTFIIB open reading frame (ORF) was amplified from MRA-296 Plasmodium falciparum 3D7 
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16hr cDNA bacteriophage (λZapII) library containing the ring stage of the parasite in 50µl 
reaction volume containing 50µM respective primers (Table 1., primers 7 & 8). In order to 
efficiently amplify A/T- rich P. falciparum sequences, the PCR elongation step was carried out at 
60˚C (Su et al., 1996).  
 
All PCR products were purified using either the MinEluteTM Reaction Cleanup Kit (Qiagen) or 
QIAquick PCR Purification Kit (Qiagen), following the manufacturer’s instructions. The purity 
and integrity of purified DNA was verified by agarose electrophoresis and DNA concentrations 
were determined with NanoDrop 2000 spectrophotometer (Thermo Scientific).  
 
 
Agarose gel electrophoresis
DNA was analysed on 0.8-2% (w/v) agarose gels containing 0.02µg/ml ethidium bromide 
(EtBR) in 0.5×TBE (40mM Tris-Cl pH 8.3, 45mM boric acid, 1mM ethylenediaminetetraacetic 
acid [EDTA]) buffer. Electrophoresis was carried out at 80V until sufficient separation. In all 
instances GeneRuler DNA ladder (Thermo Scientific) was used for size comparison and 
estimation of DNA yield. 
Restriction enzyme digestion and ligation
6His:PfTFIIB:GST construct 
The overlap extension PCR product and pET11d-6His-PfTBP was digested with BamHI 
(Thermo Scientific) and EcoRI (Fermentas) and ligated. The resulting intermediate vector, 
pET11d-6His-PfTBP-GST, was digested with BamHI (Thermo Scientific) and NdeI (Thermo 
Scientific) and PfTFIIB ORF was digested with BglII (Fermentas) and NdeI (Thermo Scientific) 
Table 1. General PCR profile for the amplification of P. falciparum sequences
Duration Temperature (C˚) Cycles
5min 95 1
30sec 95
3030sec 56
1min 60
10min 60 1
10min 72 1
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and ligated into resulting vector frame. 
 
6His:PfTFIIB, 6His:PfTFIIB∆37 & 6His:PfTFIIB∆140 constructs 
PfTFIIB∆37 and PfTFIIB∆140 PCR products and PfTFIIB ORF was digested with BglII 
(Fermentas) and NdeI (Thermo Scientific). BamHI/NdeI digested and de-phosphorylated 
pET11d-6His vector frame was provided by Dr. Thomas Oelgeschläger.  
 
QIAquick MinElute Reaction Cleanup Kit 50 (Qiagen) or QIAquick Gel Extraction Kit 50 
(Qiagen) were used for the cleanup of all restriction enzyme (RE) digestions. Manufacturer’s 
instructions were followed in all procedures. 
 
In all instances, vector frames were dephosphorylated using alkaline phosphatase (Thermo 
scientific FastAP) as specified by the manufacturer. All ligations reactions were carried out at 
room temperature (RT) for 15-60min using 1:1 and 3:1 insert to vector ratios with T4 DNA 
ligase (Thermo Scientific).  
Transformation into E. coli TOP10 cells and plasmid isolation 
In all instances, 10µl of ligation mix was transformed into 100µl OneShot® TOP 10 Chemically 
Competent E. coli cells (Invitrogen) following manufacturer’s instructions and plated on 
lysogeny broth agar plates (LB; 1% [w/v] tryptone powder, 0.5% [w/v] yeast extract, 0.5% [w/v] 
NaCl, 1.5% [w/v] agar, pH 7.5) containing 100µg/ml ampicillin. Colonies containing positive 
clones were identified by colony PCR as described above and used to inoculate 10mL lysogenic 
broth (LB; 1% [w/v] tryptone, 0.5% [w/v] yeast extract, 170mM NaCl) containing 100µg/ml 
ampicillin and grown overnight (O/N) at 37 ̊ C. Plasmid extraction was performed using 
GeneJET Plasmid Miniprep Kit (Thermo scientific) following manufacturer’s instructions. 
 
Sequencing  
The sequencing was carried out by Stellenbosch Central Analytical Facility (Stellenbosch 
University, South Africa). 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Transformation into E. coli BL21 cells for protein expression
BL21-CodonPlus (DE3)-RIL cells (BL21; Agilent Technologies) were used for the recombinant 
expression of all P. falciparum proteins. The BL21-CodonPlus (DE3)-RIL cells contain a 
chloramphenicol resistant plasmid with extra copies of genes encoding tRNA’s for arginine 
(AGA; AGG), isoleucine (AUA) and leucine (CUA) codons. Respective tRNA’s are rare in E. 
coli translation events and supplementation ensures optimal expression of proteins with high 
frequency of these codons. 
All expression vectors used in this study were transformed as described above. Transformants 
were spread plated onto Super Optimal Broth with Catabolite Repression (SOC; 2% [w/v] 
tryptone powder, 0.5% [w/v] yeast extract, 10mM NaCl, 2.5mM KCl, 10mM MgCl2, 20mM 
glucose, 1.5% [w/v] agar) plates containing 50μg/ml chloramphenicol and 100μg/ml ampicillin, 
and incubated overnight at 37°C. 
2.2.  Expression of recombinant P. falciparum proteins in E. coli
 
 
All expression cultures listed below contained 50μg/ml chloramphenicol, 100μg/ml ampicillin. 
In all instances, cell growth was monitored by measuring the optical density of the cultures (OD) 
with a commercial spectrophotometer. 
Starter culture
 
A single colony of transformed E. coli BL21 cells was used to inoculate 10-25mL of LB (1% [w/
v] glucose) and incubated O/N at 37 ̊C. The culture was centrifuged at ~12000 x g for 10min at 
4˚C and bacterial pellets re-suspended in fresh LB (1% [w/v] glucose) in order to remove 
secreted β-lactamase. Expression cultures were inoculated with starter culture in a 1:20 or 1:100 
ratio, as described. 
 
Expression of 6His:PfTBPcore  
Starter culture containing E. coli BL21 cells transformed with pET11d-6His-PfTBP was used to 
inoculate 500mL LB at a ratio of 1:100 (v/v). Expression cultures were grown at 37˚C until mid-
log phase, OD550=0.45 (~3hours). The cultures were cold shocked on ice for 90 seconds and 
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incubated for a further 16 hours (O/N) at 30˚C. The cold-shock method has been reported to lead 
to increased expression of cold-shock chaperone proteins (Qing et al., 2004), thus potentially 
reducing aggregation and improving solubility of recombinant PfTBPc. The cultures were 
pelleted by centrifugation at ~5500 x g at 4˚C for 10min and flash-frozen in liquid N2 for storage 
at -80˚C.  
 
Expression of 6His:PfTFIIB:GST 
Starter culture containing E. coli BL21 cells transformed with pET11d-6His-PfTFIIB-GST was 
used to inoculate 500mL LB (1% [w/v] glucose) at a ratio of 1:20. Expression cultures were 
grown at 37 ̊C for 5 hours and pelleted by centrifugation at ~12000 x g for 10min at 4 ̊C. For 
induced cultures, at OD600=~1.0, 0.1mM isopropyl 1-thio-ß-D-galactopyranoside (IPTG) was 
added to the culture and grown for another 2.5h. Pellets were obtained as described above and 
flash-frozen in liquid N2 for storage at -80˚C. 
Expression of 6His:PfTFIIB, 6His:PfTFIIB∆37 & 6His:PfTFIIB∆140 
Starter culture containing E. coli BL21 cells transformed with the pET11d-6His-PfTFIIB,  
pET11d-6His-PfTFIIB∆37 or pET11d-6His-PfTFIIB∆140 was used to inoculate 500mL LB at a 
ratio of 1:20. Expression cultures were grown at 37 ̊C for 5 hours and pelleted by centrifugation 
at ~12000 x g for 10min at 4 ̊C. Pellets were flash-frozen with in liquid N2 for storage at -80˚C. 
2.3.  Purification and analysis recombinant P. falciparum proteins
 
All purification procedures were carried out at 4 ̊C using gravity flow where applicable. Elution 
fractions were flash-frozen in liquid N2 and stored for analysis at -80 ̊ C. BC- buffers (20mM 
Tris, pH 7.2 at RT, 0.02mM EDTA, 10mM β-mercaptoethanol, 0.1% NP 40) were used for 
protein storage and purification, with the respective KCl concentration indicated (e. g. BC-100 
contains 100mM KCl).  
 
Isolation of soluble proteins from E. coli cellular lysates 
The following procedures were carried out on ice. Cell pellets were resuspended in sonication 
buffer (50mM Tris-HCl, 300mM KCl, 0.2% Nonidet P-40 [NP-40], 10mM ß-mercaptoethanol 
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[ß-EtSH]) with the addition of protease inhibitor cocktail (50µl/g per cell pellet; P8340 Sigma-
Aldrich ), lysozyme (0.5mg/ml; Sigma-Aldrich) and Benzonase (1µl/5g cell pellet; E1014 
Sigma-Aldrich). The cell suspension was left on ice for 30min followed by sonicated in 6x10s 
bursts with 50s cooling on ice between bursts. The resulting cell lysate was centrifuged at 30000 
x g for 30min at 4 ̊C to obtain cleared lysate. 
 
Purification of 6His:PfTBPc by Nickel-affinity chromatography and ion exchange 
chromatography
 
6His:PfTBPc was purified from cleared lysate on Nickel-Nitrilotriacetic acid (Ni-NTA) agarose 
(Nickel Affinity Gel, Sigma-Aldrich) in Poly-Prep® Chromatography columns (Bio-Rad). 
Cleared lysate was passed through the column, washed with 20x packed column volume (PCV) 
of wash buffer (20mM Tris-HCl pH 7.2, 100mM KCl, 10mM ß-EtSH, 0.1% NP-40, 20mM 
imidazole), and eluted with ~5 PCV of elution buffer (20mM Tris-HCl pH 7.2, 20% (v/v) 
glycerol, 0.2mM EDTA, 100mM KCl, 10mM ß-EtSH, 0.1% NP-40, 250mM imidazole). 
200-600µl elution fractions were collected in sterile eppendorf tubes. 
 
Ni-NTA agarose elutions were analysed by SDS PAGE and 6His:PfTBPc containing fractions 
pooled and adjusted to 500mM KCl using PD-10 Desalting columns (GE Healthcare), according 
to manufacturer’s instructions. PfTBPc was further purified on PureProteomeTM nickel magnetic 
beads (Ni-beads; Millipore) as specified by manufacturer, with following adaptions: cleared 
lysate was incubated with the beads at 4 ̊C with shaking for 1h and beads separated from the 
unbound protein fraction using a magnetic separator; Ni-NTA agarose elution buffer was as 
described above. 
 
Further purification using ion exchange chromatography was carried out by Dr. Thomas 
Oelgeschläger. Briefly, Ni-NTA elution fractions were pooled, adjusted to 100mM KCl using 
PD-10 Desalting columns (GE Healthcare), and subjected to Sulphopropyl- Sepharose® Fast 
Flow (SP-Sepharose; Sigma-Aldrich) and eluted in a stepwise manner with BC-120 up to 
BC-280 (20mM KCl steps), followed by BC-300 and BC-500. Protein containing fractions were 
identified by SDS PAGE, pooled and adjusted to 100mM KCl using PD-MidiTrap G-25 
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desalting columns (GE Healthcare), and passed over Q-Sepharose® Fast Flow (Sigma Aldrich). 
Protein containing fraction was recovered in the flowthrough. 
 
Purification of 6His:PfTFIIB:GST by glutathione and nickel affinity chromatography
 
Glutathione-agarose  (GSH)  resin  (Sigma-Aldrich)  was  prepared  following  manufacturer’s 
instructions. Cleared lysate was subjected to the resin, followed by wash with 20x PCV of wash 
buffer (20mM Tris-HCl pH 7.2, 0.2mM EDTA, 100mM KCl, 10mM ß-EtSH, 0.1% NP-40) and 
bound proteins were eluted with glutathione elution buffer (20mM Tris-HCl pH 7.2, 20% (v/v) 
glycerol 0.2mM EDTA, 100mM KCl, 10mM ß-EtSH, 0.1% NP-40, 20mM glutathione). The 
GSH eluates were loaded onto Ni-NTA agarose HIS- Select® HF Nickel Affinity Gel (Sigma-
Aldrich), followed by wash with 20x PCV of wash buffer. The proteins were eluted in NI-NTA 
elution buffer, as described above. 
 
Purification of 6His:PfTFIIB by nickel affinity chromatography and ion exchange 
chromatography
 
Ni-NTA agarose HIS- Select® HF Nickel Affinity Gel (Sigma-Aldrich) was prepared as 
specified by manufacturer and purification procedure followed as described above. Ni-NTA 
agarose purification elution fractions were pooled and buffer exchanged into fresh BC-100 (20 
mM Tris, pH 7.2 at RT, 100mM KCl, 0.02mM EDTA, 10mM β-EtSH, 0.1% NP 40) using PD-10 
Desalting column (GE Healthcare), according to manufacturer’s instructions.  
SP-Sepharose (Sigma-Aldrich) resin was prepared as specified by the manufacturer and 
equilibrated in BC-100 buffer. Pooled Ni-NTA agarose elution fractions were passed over SP-
Sepharose and flowthough collected. The resin was washed with 5x PCV of BC-100, and bound 
proteins were stepwise eluted with 4x PCV of BC-buffer, containing 200mM KCl, followed by 
350mM and 500mM KCl. ~500µl fractions were collected in sterile eppendorf tubes. 
 
SDS PAGE analysis 
 
In all instances the Mini-PROTEAN® Electrophoresis System (Bio-rad) was utilised. 12-15% 
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resolving and 5% stacking gels were prepared according to standard protocol (Sambrook and 
Russell, 2001). Samples were mixed in a 1:1 ratio with 2×SDS loading dye (100 mM Tris-Cl 
(pH 6.8), 4% [w/v] SDS, 0.2% [w/v] bromophenol blue, 20% [v/v] glycerol, 200mM 
dithiothreitol [DTT]) and heated at 80°C for 2 minutes. Samples were electrophoresed at a 
constant amperage of 40mA until completion. The gels were washed in deionised water for 3 x 
10 min, stained with Bio-SafeTM G-250 Coomassie premixed stain (Bio-Rad) for 30 minutes and 
subsequently destained with deionised water. In all instances, Precision Plus All Blue (Bio-Rad) 
and Color Prestained Protein Standard (NEB) molecular weight (MW) markers were used, as 
indicated in figure legends.  
 
Immunoblot analysis 
 
Immunoblots were performed utilising the Mini Trans-Blot® Electrophoretic Transfer Cell (Bio-
Rad) apparatus, following manufacturer’s instructions.  
Proteins of interest were separated on SDS PAGE and transferred to a Millipore Immobilon-P 
transfer membrane (PVDF) using a standard protocol (Sambrook and Russell, 2001). The 
membrane was washed in 1×TBST buffer (137mM NaCl, 2.7mM KCl, 19mM Tris, 1% 
Tween-20 [Sigma-Aldrich]) 3 times for 5 minutes, followed by deionised H2O. The membrane 
was stained for 1 hour with Colloidal Gold Total Protein Stain (Bio-Rad), followed by wash with 
deionised H2O. The membrane was washed 3 times with 1×TBST buffer and blocked with 5% 
[w/v] fat-free milk in 1×TBST for 30min at RT and incubated with the appropriate antisera/
purified antibody (1:500 and 1:1000 dilution, respectively, in 5% [w/v] fat-free milk in 1×TBST) 
for 2h at RT or O/N at 4˚C. The membrane was washed with 3 times with 1xTBST and 
incubated with horseradish peroxidase-conjugated anti-rabbit IgG (1:3000 in 1xTBST; Sigma-
Aldrich) for 30min at RT, followed by 3 x wash with 1xTBST. Immunoreactant proteins were 
visualised with Pierce® ECL Western blotting substrate (Thermo Scientific), according to 
manufacturer’s protocol on X- ray film (CL-XPosure, Thermo Scientific).  
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2.4.  Affinity purification of antibodies for PfTBP, PfTFIIB and PfTFIIAα/β
 
Polyclonal rabbit peptide antibodies against PfTBP (residues 125- 138: C-SEYDNNE 
KEKSDDL), PfTFIIB (residues 354-367: C-LKQKYLSEDKRKKN) and PfTFIIAα/β 
(residues:C-GLVSNKKENKNSKI) were produced by BioGenes (Berlin, Germany). The 
presence of the peptide antibodies in the rabbit antisera was confirmed by ELISA. Further 
purification of the polyclonal antibodies from rabbit antisera was carried out using antigen-
affinity purification. Peptides were coupled to SulfoLink™ Coupling Resin (Thermo Scientific) 
and antigen-affinity purification was carried out following the protocols by the Hyman Lab at 
the Max Planck institute of Molecular Cell Biology & Genetics (detailed protocol can be 
accessed at: http://hymanlab.mpi-cbg.de/hyman_lab/), with the following adaptions: the PfTBP, 
PfTFIIB or PfTFIIAα/β lypholized peptide was dissolved in 50mM Tris, 5mM EDTA, pH 8.5 to 
1mg/mL and incubated in the resin for 30min at RT; serum was diluted with an equal volume of 
20mM Tris pH 7.5, centrifuged at 20000x g at 4 ̊ C for 30min and decanted into a sterile 
container; bound antibodies were eluted with 100mM glycine pH2.5 followed by 100mM 
triethylamine pH11.5. 10µl diluted BioRad Protein Assay Reagent (BioRad) was mixed with 
50µl elution fractions and antibody-containing fractions were identified and pooled. The pooled 
fractions were dialyzed against 3 x 2L phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM 
KCl, 10mM Na2HPO4, 1.8mM KH2PO4) and concentrated using Nanosep® Centrifugal Device 
with Omega Membrane 10K (Pall), according to the manufacturer’s instructions. Purified 
antibodies were analysed on SDS PAGE and protein concentration determined by BioRad 
Protein Assay (BioRad), according to manufacturer’s instructions. 
2.5.  DNA-binding assays
 
The DNA-binding  activities  of  PfTBP and  PfTFIIB are  investigated  using  two independent 
approaches - electrophoretic mobility shift assays (EMSAs) and immobilised template assays 
(ITAs). 
Electrophoretic mobility shift assays
 
Electrophoretic mobility shift assay (EMSA) is a well established method of identifying protein-
DNA complexes (Garner and Revzin, 1981). The classical method is based on autoradiographic 
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detection of the mobility of 32P-labelled nucleic acid in a native gel matrix. The nucleic acids are 
incubated with the protein of interest and upon DNA-binding activity of the proteins the relative 
mobility of the DNA decreases, resulting in a slower migrating protein-DNA complex, i. e. a 'gel 
shift' (Hellman and Fried, 2007). Chemiluminescence detection is a common alternative to 
radiographic detection (Rodgers et al., 2000) and was utilised in this study. In this method, the 
target DNA 5’ and 3’ ends are labelled with biotin which interact with streptavidin- conjugated 
horseradish peroxidase resulting in chemiluminescence upon addition of substrate. The 
biotinylated, electrophoresed DNA probes are transferred to a positively charged nylon 
membrane, incubated with the streptavidin conjugate and luminescence is detected by X-ray 
film. In this study, polyacrylamide gels as well as Mg2+ agarose gels were used. Magnesium-
containing agarose gels have been used as an alternative to non-denaturing polyacrylamide 
(Hellman and Fried, 2007), as larger pore size of agarose allows for the resolution of large multi-
protein complexes (Zerby and Lieberman, 1997). 
 
Immobilised template assays
 
Immobilised template assays are commonly used to study protein-DNA interactions and 
cooperative binding of pre-initiation complexes (Johnson et al., 2004). It provides an alternative 
for the investigation of large complexes that are often difficult to resolve in EMSAs and provides 
further evidence for specific protein-DNA interactions. In this assay, DNA probes are 5’ 
biotinylated and immobilised on streptavidin-coated magnetic DynabeadsTM. DNA-binding 
proteins are incubated with the immobilised beads and unbound fraction is removed by 
separating the immobilised template with a magnetic particle concentrator. The bead pellet is 
washed to ensure the elimination of non-specific binding and proteins bound to the template 
DNA are eluted and detected by immunoblotting. 
Promoter sequences used in this study
 
The promoter regions of two Plasmodium-specific genes, kahrp and gbp-130, and the eukaryotic 
model promoter, adenovirus 2 major late (Ad2ML), were chosen for DNA binding assays. The 
adenovirus 2 promoter contains a classical TATA-box motif, and has been widely utilised in 
eukaryotic transcription studies (Thomas and Chiang, 2006). This promoter allows for 
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comparison with respective human transcription factors and for the identification of potential 
sequence preference of Plasmodium factors.  
The Plasmodium genes chosen for this study, kahrp and gbp-130, are involved in mediating the 
pathogenicity of the parasite in humans. The gbp-130 gene encodes glycophorin binding protein- 
an essential mediator which binds erythrocyte binding protein and initiates the invasion of RBCs 
by the parasite (Perkins, 1984). The kahrp gene encodes knob-associated histidine-rich protein, 
which has been shown to interact with erythrocyte membrane skeleton proteins. Studies link 
these interactions to cytoadherence of RBCs, which is the main determinant of the 
pathophysiology of malaria (Pei et al., 2005, Weng et al., 2014).  
Few studies have investigated these genes to date. Proteins from Plasmodium nuclear extracts 
have been shown to associate with gbp-130 and kahrp promoter regions in a stage-specific 
manner, and the TSS have been mapped (Lanzer, 1992a, Lanzer, 1992b). PfTBP binding of the 
promoter regions of these genes has been demonstrated as by Ruvalcaba-Salazar et al (2005). 
The aforementioned study mapped PfTBP binding to TATA-like elements in regions located at 
-81 and -186bp relative to TSS. The probes used in this MSc research were designed to 
accommodate this observation, spanning approximately +60 to -170 from the reported TSS, 
resulting in 282bp sequences (see Table 2). The Ad2ML promoter used was 297bp in length. All 
EMSA DNA probes were 5’ and 3’ double biotinylated. 
 
The upstream region of highly variable (var) genes, was identified as a region of interest in this 
study and included as DNA target for PfTFIIB in polyacrylamide EMSAs. The var genes encode 
PfEMP1 that confers antigenic variation and is the parasite’s main mechanism of evading host 
immune attack (see Chapter 1) (Kirkman and Deitsch, 2012). The upstream regions of var genes 
are highly conserved, with deletions leading to promoter inactivation in transgenic P. falciparum 
lines (Brancucci et al., 2012). Therefore, a 60bp probe spanning from -80 to -21 relative to TSS, 
including a conserved 31bp region of var 5B1 identified previously by Voss et al. (2000), was 
included in this study. 
 
The Ad2ML, kahrp and gbp-130 promoter regions were also used in ITAs (Table 2). In order to 
avoid steric hindrance, the ITA probes were amplified with five GAL4 binding sites, allowing 
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for sufficient space between potential DNA binding sites and magnetic beads. The P. falciparum 
ITA probes were therefore longer (422bp) and were biotinylated only at the 5’ end. 
 
Preparation of DNA probes used in EMSAs and ITAs
 
Vectors containing the Plasmodium promoter sequences were produced by Tomas Hessler, an 
Honours research student in the laboratory. In brief, the regions spanning +51 to -181bp relative 
to the gbp-130 TSS and +63 to -172 relative to the kahrp TSS and were amplified from 
Plasmodium 3D7 genomic DNA library and cloned into a pGEM-7Zf (Promega) derived vector. 
The Ad2ML probe was amplified from the pTOG5ML(-51TATA/+62) vector (Oelgeschlager et 
al., 1998). The kahrp, gbp-130 and Ad2ML promoter regions were PCR amplified with 
biotinylated primers and purified using QIAquick Gel Extraction Kit 50 (Qiagen).  
 
The var probe oligonucleotides were synthesised by the Oligonucleotide Synthesis lab 
(UCT@MCB, Cape Town). 10µM (+) and (-) strands were hybridised by heating in Tris-EDTA 
(TE, Tris-HCl pH 7.2, 1mM EDTA) containing 50mM NaCl at 95˚C for 5min and allowed to 
cool to RT over ~30min. The annealed oligonucleotides were resolved by PAGE and purified 
using QIAEXII Gel Extraction Kit (Qiagen), according to the manufacturer’s instructions.  
 
Unbiotinylated oligonucleotide competition probes
Unlabelled full length kahrp, gbp-130 and Ad2ML promoters were amplified as described above 
using unbiotinylated primers. TATA-containing and TATA-less sequences were amplified from 
the pTOG5TdT(-41TATA/+33) and pTOG5TdT(-41/+33) vectors (Malecova et al., 2007). 
Primers for the amplification of kahrp promoter regions spanning nucleotides 1-138 (termed 
kahrp A) and 125-282 (termed kahrp B) of the original 282bp kahrp EMSA probe were designed 
using SerialCloner (Version 2.6.1, SerialBasics), melting temperatures and self-complementarity 
of the primers was checked using OligoCalc (www.basic.northwestern.edu/biotools/
oligocalc.html). 
The double stranded copolymer poly(dG-dC) (Sigma-Aldrich) was used to compete with the 
target DNA sequence for non-specific binding of the proteins of interest.
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Table 2. DNA probes used in ITAs and EMSAs.  PCR primer sequences in UPPERCASE, 
GAL4  binding  sites  uppercase  ITALICS,  TSS  indicated  in  red.  Known  TATA-consensus 
sequences in TdT and Ad2ML promoters indicated in black.
EMSA PROBES
Promoter region Sequence Length (bp) Biotinylated
kahrp
5’CGAGCGGAGACTCTAGAATTCtgatgatatgttt
tatatttcttgttttaaattattagaataaaaagaaataattattattt
catggaaataatataatattattatttttttttttaattatttagtagttat
gttttgtcgttttttctcatttatttattataatttacctatagtatatacta
tgatgtatatttactctagtatgaagaataaagttaatgtaaaata
ttactacactacatgcagttttaGGATCCGGAGAGCTC
CCAACGCGTT-3’ 
282
5’ and 3'  
OR 
no
gbp-130 
5’CGAGCGGAGACTCTAGaattctttgaagtacactc
aaaataagttatataccatatgtttttaacatatattatatatatata
tatatatataatataatataatattataattattttttaatattattaaat
tgaacataattattttatatcttactattatttttagaaaatttattatat
atacatgcaatcataaataatgttttccctgaaccttttttcaatga
aataagttaacacaccattccttttGGATCCGGAGAGC
TCCCAACGCGTT-3’ 
282
5’ and 3'  
OR 
no
Ad2ML
5’-AATTGGGCCCGACGTCGCAtgctcctctag
ctgaagcttgcatgcctgcaggtcggagtactgtcctccgagc
ggagtactgtcctccgagcggagtactgtcctccgagcggagt
actgtcctccgagcggagtactgtcctccgagcggagactcta
ggggtgttcctgaaggggggctataaaagggggtgggggcg
cgttcgtcctcactctcttccgcatcgctgtctgcgagggccagc
tgttggggtgagtactccctctcaaaaggatccGGAGAGC
TCCCAACGCGTT-3'
297
5’ and 3'  
OR  
no
var 5’-atatatgtatttattttcatagaaatgtggtagataatatagatagaaaggtaatatttc-3’ 60 5’ and 3'
kahrp A
5’-CGAGCGGAGACTCTAGAATTCtgatgatatgtt 
ttatatttcttgttttaaattattagaataaaaagaaataattattattt
catggaaataatataatattattatttttttttttaattatttagtagttat
gtt-3’
138 no
kahrp C
5’-tagtagttatgttttgtcgttttttctcatttatttattataatttacc
tat agtatatactatgatgtatatttactctagtatgaagaataaa
gttaatgtaaaatattactacactacatgcagttttaGGATCC
GGAGAGCTCCCAACGCGTT-3’
157 no
TdT TATA
5’-CGAGCGGAGACTCTAGAATTCggtacctat 
gtataaaatggtgagaggacatcagagccctcattctggaga
caccacctgatggcacagacagaggatccg 
GAGAGCTCCCAACGCGTT-3’
126 no
TdT ∆TATA
5’-CGAGCGGAGACTCTAGAATTCgagctcggt 
acctatgggtctgctggtgagaggacatcagagccctcattctg 
gagacaccacctgatggcacagacagaggatccgGAGA
GCTCCCAACGCGTT-3’
120 no
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DNA immobilisation on streptavidin magnetic beads
 
Biotinylated probes were bound to Dynabeads® M-280 streptavidin beads (Dynabeads, 
Invitrogen) following the manufacturer’s instructions. Probe-bound beads were resuspended in 
1x wash buffer (10mM Tris-Cl pH 7.5 at RT; 0.5mM EDTA; 1M NaCl) containing 100ng/µl 
bovine serum albumin (BSA). The binding efficiency of the beads was tested by resuspending an 
aliquot of the beads in deionised water and heating at 70°C for 2min with agitation. Supernatant 
was separated from the beads using a magnetic separator and resolved by 1.5% agarose gel 
electrophoresis and quantified using DNA MW marker.  
ITA PROBES
Promoter region Sequence Length (bp) Biotinylated
kahrp
5’AATTGGGCCCGACGTCGCATGCTCCTCTA
GAGCTTGCATGCCTGCAGGTCGGAGTACT
GTCCTCCGAGCGGAGTACTGTCCTCCGAG
CGGAGTACTGTCCTCCGAGCGGAGTACTGT
CCTCCGAGCGGAGTACTGTCCTCCGAGCG
GAGACTCTAGAATTCtgatgatatgttttatatttcttgtttt
aaattattagaataaaaagaaataattattatttcatggaaataa
tataatattattatttttttttttaattatttagtagttatgttttgtcgttttttc
tcatttatttattataatttacctatagtatatactatgatgtatatttac
tctagtatgaagaataaagttaatgtaaaatattactacactaca
tgcagttttaGGATCCGGAGAGCTCCCAACGCG
TT-3’ 
422 5’ 
gbp-130
5’AATTGGGCCCGACGTCGCATGCTCCTCTA
GAGCTTGCATGCCTGCAGGTCGGAGACTG
TCCTCCGAGCGGAGTACTGTCCTCCGAGC
GGAGTACTGTCCTCCGAGCGGAGTACTGTC
CTCCGAGCGGAGTACTGTCCTCCGAGCGG
AGACTCTAGAATTCtttgaagtacactcaaaataagtta
tataccatatgtttttaacatatattatatatatatatatatatataata
taatataatattataattattttttaatattattaaattgaacataatta
ttttatatcttactattatttttagaaaatttattatatatacatgcaatc
ataaataatgttttccctgaaccttttttcaatgaaataagttaaca
caccattccttttGGATCCGGAGAGCTCCCAACGC
GTT-3’ 
422 5’ 
Ad2ML
5’AATTGGGCCCGACGTCGCAtgctcctctagctga 
agcttgcatgcctgcaggtcggagtactgtcctccgagcggagt
actgtcctccgagcggagtactgtcctccgagcggagtactgtc
ctccgagcggagtactgtcctccgagcggagactctaggggtg
ttcctgaaggggggctataaaagggggtgggggcgcgttcgt
cctcactctcttccgcatcgctgtctgcgagggccagctgttggg
gtgagtactccctctcaaaaggatccGGAGAGCTCCCA
ACGCGTT-3'
297 5'
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Native PAGE EMSA 
Binding reactions of 10µl were prepared combining 4µl template mix prepared in transcription 
buffer (containing required amount of DNA probe and competitor DNA or poly(dG-dC)) and 6µl 
protein mix (containing tested proteins in BC-100) for a final transcription buffer composition of 
20mM 4-(2- hydroxyethyl)-1-piperazineethanesulfonic acid pH 8.0 (HEPES), 5mM MgCl2, 
5mM DTT, 100ng/µl BSA. Binding reactions were incubated at 30 ̊C, RT or on ice for 45min. 
Prior to sample loading, 5% 37:1 polyacrylamide gels (0.5xTBE, 0.5mM DTT, 2mM MgCl2) 
were pre-run at 4 ̊ C for 1h at 100V in 0.5x TBE containing 2mM MgCl2. Complexes were 
separated by electrophoresis as above at 4 ̊ C for 2h at 100V. Bio-Rad Mini Trans-Blot® 
Electrophoretic Transfer Cell was used for the transfer of gel to Immobilon-Ny+ nylon 
membrane (Merck Millipore) in ice-cold 0.5x TBE at 4 ̊ C for 2h at 100V. The DNA was 
crosslinked to the membrane using 4x 120mJ/cm2 commercial UV-light cross linker and 
visualised on X-ray film using the Chemiluminescent Nucleic Acid Detection Module (Thermo 
Scientific). 
Mg2+ agarose EMSA 
Binding reactions were prepared as above. Where applicable, antibodies were included in the 
protein  mix  and  pre-incubated  for  15min  on  ice.  Binding  reactions  were  resolved  by  1.4% 
agarose gel (0.5x TBE; 5mM MgCl2) at 4 ̊C for 2h at 100V in 0.5x TBE containing 2mM MgCl2. 
The agarose gels were not pre-run prior to sample loading. 
A 240mbar diaphragm pump (Charles Austen DA7C) was utilised in conjunction with a southern 
blotting apparatus (ATTO, USA) to construct a horizontal  vacuum-transfer module for Mg2+ 
agarose EMSA gels. The gel was placed on a vacuum-proof mask covering the nylon membrane 
and subjected to vacuum for 1.5h at RT. Vacuum pressure was controlled by an adapted switch 
with an adjustable airlock and set to a strength at which from visual observation <50% of the gel 
was contracted. Following transfer, DNA was crosslinked and visualised as above. 
 
Immobilised template assay
 
Binding reactions of 40µl were prepared in transcription buffer detailed above using probes 
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immobilised on streptavidin magnetic beads. Because the protein of interest interacting with 
DNA is identified by a specific antibody, the amount of protein bound to the DNA has to be 
sufficient for antibody detection. For this reason, 1pmol of DNA probe immobilised on 
streptavidin beads was used in this assay. Equivalent amount of free streptavidin magnetic beads 
were used to control for  non-specific protein interactions with the magnetic beads.  
The DNA-bound and free beads were equilibrated in standard transcription buffer, followed by 
incubation with the binding reactions for 45 minutes at 30°C. Following incubation, the unbound 
fraction was separated from the beads using a magnetic separator and mixed with 15µl 4x 
Laemmli Sample Buffer (Bio-Rad) supplemented with 1M ß-EtSH. The beads were washed in 
100µl of transcription buffer and resuspended in 40µl of transcription buffer and 15µl 4x 
Laemmli Sample Buffer (Bio-Rad) supplemented with 1M ß-EtSH. The samples were heated at 
80°C for 2 minutes and resolved by SDS PAGE and visualised by immunoblotting, as described 
above. 
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3. Results 
3.1.  Expression and purification of PfTBP 
 
3.1.1. Cloning of 6His:PfTBPc
 
The expression vector for PfTBP was cloned previously and generously provided by Dr. Thomas 
Oelgeschläger. This vector expresses 6His- tagged PfTBP amino acids 100-327 (PfTBP ‘core’ = 
PfTBPc), containing the evolutionarily conserved C-terminal DNA-binding domain and residues 
100-147 of the N-terminus. For a detailed plasmid map of 6His:PfTBPc see Appendix A.
3.1.2. Expression and purification of 6His:PfTBPc  
The chosen expression system for the bacterial expression of all recombinant P. falciparum 
proteins was the T7 promoter system expressed in E.  coli  BL21-CodonPlus-(DE3)-RIL cells. 
The protein of interest is cloned into plasmid pET11d, downstream of the T7 promoter. The 
BL21-CodonPlus-(DE3)-RIL strain encodes T7 polymerase that is expressed under the control 
of the IPTG-inducible lacUV5 promoter. 
 
Recombinant 6His:PfTBPc expression
6His:PfTBPc expression conditions were established previously in the lab by Robert Milton. 
Briefly, initial cell mass was generated by an overnight starter culture with media containing 1%
(w/v) glucose. Expression media lacking glucose was inoculated with starter culture at a ratio 
1:100 (v/v) and incubated at 37˚C until mid-log phase (OD550 = ~0.5). The cultures were cold-
shocked on ice for 90s and incubated at 30˚C in the absence of IPTG inducer for 16 hours. The 
cultures were not induced with IPTG, as similarly to the PfTFIIB expression (Chapter 3.4), 
IPTG induction led to reduced growth rate and cell death (Robert Milton, unpublished 
observations). A detailed expression protocol is provided in Chapter 2.2. 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Purification of 6His:PfTBPc 
6His:PfTBPc was affinity purified via the 6His-tag using Ni-NTA agarose resins. The Ni-NTA 
agarose elution profile of 6His:PfTBPc purified from cleared bacterial lysate was broad and 
preliminary immobilised template assays showed that the late fractions had significantly higher 
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Figure 6. 6His:PfTBPc purification with Nickel affinity resins
A. SDS PAGE analysis of PfTBPc fractions, purified by Ni-NTA resin and nickel magnetic 
beads.  
6His:PfTBPc was purified by Ni-NTA agarose from cleared bacterial lysates, buffer exchanged 
into BC-500 (500mM KCl), followed by purification with Ni-NTA magnetic beads. Eluates 
were analysed by SDS PAGE with comparison to known amounts of BSA. Equivalent amounts 
of pooled Ni-NTA agarose eluate before (NI) and after buffer exchange to 500mM KCl (BE), 
Ni-NTA magnetic bead flowthrough (FT) and 10µl (1/80th of the total elution volume) of each 
elution fraction was resolved by 15% SDS PAGE. The relative position of protein MW 
standards (BioRad Precision Plus All Blue) and the band corresponding to 6His:PfTBPc is 
indicated.  
B. Immunoblot analysis of 6His:PfTBPc purification on Ni-NTA beads.  
Ni-NTA magnetic bead purification elution fractions 1 and 2 (3µl; corresponding to lanes 4,5; 
panel A) were resolved by 15% SDS PAGE, transferred to a PVDF membrane and probed with 
a 1:500 dilution of α-PfTBP rabbit antisera. X-ray film exposure time: 10s. The 67kDa band 
indicated by an asterisk (*), corresponds to BSA added to the fraction at a concentration of 
100ng/µl, which at this high concentration cross-reacts with the α-PfTBP rabbit antisera.
DNA-binding activity compared to the early fractions (data not shown). It is possible that the 
reduced binding activity was caused by aggregation due to high PfTBPc concentration in the 
early fractions. In order to reduce ionic interactions between proteins in solution and alleviate 
aggregation, the Ni-NTA eluates were pooled, adjusted to 500mM KCl using desalting column 
(PD-10, GE Healthcare), and re-purified using Ni-NTA magnetic beads. 6His:PfTBPc eluted 
from Ni-NTA magnetic beads mostly in the first fractions (Fig. 6A). Selected fractions were 
analysed with α-PfTBP rabbit antisera (Fig. 6B), confirming the identity of 6His:PfTBPc.  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Figure 7. PfTBPc purification using ion chromatography.
A. Overall 6His:PfTBPc purification scheme  
B. SDS PAGE analysis of 6His:PfTBPc, purified according to the presented scheme (details 
provided in Chapter 2.3). Q-Sepharose flowthrough (15µl) was resolved by 5%/15% SDS 
PAGE. A contaminant at 70kDa indicated by an asterisk (*). The relative position of protein 
MW standards (BioRad Precision Plus All Blue) is indicated.
The purity of the 6His:PfTBPc preparation was not sufficient at this stage for electrophoretic 
mobility shift assays and further purification with ion exchange resins was carried out by Dr. 
Thomas Oelgeschläger. PfTBPc has a calculated pI of 9.3 and is therefore expected to bind to 
cation exchange resins. Briefly, the Ni-NTA elutions were pooled, adjusted to 100mM KCl using  
desalting column (PD-10, GE Healthcare), bound to strong cation exchange resin, SP-Sepharose 
Fast Flow (Sigma-Aldrich), and eluted with 500mM KCl. The eluates were adjusted to 20mM 
KCl as above, and passed over Q-Sepharose Fast Flow (Sigma-Aldrich), in order to bind 
remaining contaminants and recover purified 6His:PfTBPc in the flowthrough (purification 
scheme presented in Fig. 7A). As seen in Fig. 7B, the majority of the Ni-NTA co-purified 
contaminants were removed by ion chromatography and the 6His:PfTBPc preparation contains 
only one detectable protein contaminant at ~70kDa. The 6His:PfTBPc preparation presented in 
Fig. 7B was utilised in subsequent DNA binding assays.
3.2.  Initial characterisation of PfTBP in DNA binding assays
3.2.1. PfTBP binds to immobilised gbp-130 and Ad2ML promoter DNA
Initial assessment of PfTBP binding activity was performed by immobilised template assay 
(ITA), that allows direct detection of DNA-bound protein with specific antibodies by 
immunoblot. 6His:PfTBPc was incubated with a putative P. falciparum promoter gbp-130 or 
with the eukaryotic model promoter, adenovirus 2 major late (Ad2ML), immobilised on 
magnetic beads. To control for non-specific interactions of PfTBP with the magnetic beads, 
PfTBP was also incubated with free beads. After separating the bound and unbound fractions, 
the bound fractions were washed extensively in order to eliminate any residual unbound proteins 
and analysed using α-PfTBP antibody. As seen from Figure 8, the majority of PfTBP was 
detected in the bound fractions for both gbp-130 and Ad2ML DNA templates. Conversely, the 
majority of PfTBP did not bind to the free beads, showing that the protein detected on gbp-130 
and Ad2ML was interacting with the immobilised target DNA, rather than the beads. These 
results provide strong evidence that the purified PfTBP was indeed active and had DNA-binding 
activity. Furthermore, PfTBP bound to gbp-130 and Ad2ML promoters to a similar extent, 
suggesting that both DNA probes are bound with similar binding affinity under these conditions.    
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To assess the DNA sequence specificity of PfTBP, PfTBP binding to the gbp-130 promoter was 
challenged with poly(dG-dC) competitor DNA. Minimally, a 8-fold molar excess of competitor  
was required to disrupt PfTBP binding to gbp-130 (data not shown). The high excess of non-
specific competitor DNA necessary to outcompete gbp-130 for PfTBPc binding may imply 
preferential PfTBP binding to A/T-rich DNA sequences.  
Taken together, these results confirm the direct binding of PfTBP to the model promoter 
sequences, providing the basis for further investigation of DNA-binding by EMSA. 
3.2.2. Temperature dependence of PfTBP DNA-binding
Initial EMSAs with Plasmodium proteins using native polyacrylamide gels resulted in 
quantitative probe retention in the wells (data not shown). Protein concentration-dependent 
decrease of the free probe corresponded to the increase of probe retained in the wells. Therefore, 
it was concluded that the proteins under investigation possess DNA-binding activity that cannot 
be resolved under these conditions. Variation of the acrylamide:bis-acrylamide ratio, 
electrophoresis conditions, and KCl concentration of the binding reactions, did not help to 
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Figure 8. PfTBP binds to Ad2ML and gbp-130 promoters. 
Immunoblot analysis of PfTBP binding to immobilised gbp-130 and Ad2ML model promoters. 
DNA-binding reactions (40µl) contained 50ng 6His:PfTBPc and 1pmol of immobilised 
Ad2ML, gbp-130 promoter DNA or free beads, as indicated. Input (20ng; In), 50% of unbound 
(Ub; lane 3) and an equivalent amount of bound fraction (B; lane 2) were analysed by 
immunoblot with α-PfTBP antibody (1:500). X-ray film exposure: 30s. Note that all panels 
originate from the same gel with the same input. 
resolve protein-bound probe in the gel. For this reason, the protocol was adjusted for Mg2+ 
agarose gels (for details see Chapter 2.5), that is used as an alternative to non-denaturing 
polyacrylamide gels (Hellman and Fried, 2007), as larger pore size of agarose allows for the 
resolution of large multi-protein complexes (Zerby and Lieberman, 1997).  
In order to assess PfTBP DNA-binding activity in Mg2+ agarose EMSA, 10fmol of kahrp 
promoter DNA was incubated with 12ng of 6His:PfTBPc in standard transcription conditions. 
The protein-DNA complex formation was highly variable between different experiments (data 
not shown). The variable duration of binding reactions on ice prior to electrophoresis correlated 
with the differential protein-DNA complex formation. Therefore, the effect of the incubation of 
6His:PfTBPc with DNA probe at standard 30˚C and on ice (~4˚C) was compared. As seen in 
Figure 9, binding of PfTBP and smearing of the probe was observed after 30˚C incubation. In 
order to assess the stability of the complexes, poly(dG-dC) competitor DNA was included in the 
binding reactions. In the presence of 400ng poly(dG-dC), complete disruption of the complex 
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Figure 9. PfTBP-DNA complex formation is temperature-dependent.
Analysis of 6His:PfTBPc binding to the kahrp promoter by Mg2+agarose EMSA. 
Binding reactions (10µl) contained 20fmol 282bp kahrp promoter DNA, 100ng (lane 3), 200ng 
(lanes 4, 7) or 400ng (lanes 5, 8) poly(dG-dC), as indicated, and 12ng of 6His:PfTBP. Binding 
reactions were incubated at 30 ̊C or 4 ̊C for 45min, as indicated. Protein-DNA complexes were 
resolved in 1.4% agarose gels (0.5xTBE; 5mM MgCl2). X-ray film exposure: 2s.
formed at 30˚C was observed, with the majority of the free probe recovered (Fig. 9, compare 
lanes 2 and 5). This is consistent with the findings in ITAs using similar amount of competitor. 
Upon incubation on ice, DNA probe was quantitatively bound by PfTBP, forming a clear gel 
shift with significantly reduced smearing compared to the complex formed at 30˚C. Challenge 
with 400ng poly(dG-dC) competitor DNA recovered some free probe, with an estimated 50% of 
probe remained in the complex (Fig. 9, compare lanes 6 and 8).  
The difference in appearance of the mobility shifts formed at 30˚C and on ice, and sensitivity to 
poly(dG-dC) competitor indicates a quantitative and qualitative difference in PfTBP binding. 
Firstly, PfTBP binds more probe when binding reactions are incubated on ice (Fig. 9, compare 
lanes 2 and 6). It seems possible, that 6His:PfTBPc incubation at higher temperatures might 
cause partial denaturation, leading to reduced DNA-binding activity. Secondly, complexes 
formed on ice have a lesser extent of probe smearing and are less sensitive to challenge by 
poly(dG-dC) competitor compared to complexes formed at 30˚C (Fig. 9, compare lanes 3-5 and 
lanes 7-8). Smearing is observed in electrophoresis conditions with unstable complexes, where 
rapid dissociation of the protein from the DNA does not allow for clear resolution of the mobility 
shift. Therefore, besides increased binding of the probe, PfTBP complexes formed on ice also 
appear to have higher stability than complexes formed at 30˚C. Taken together, in contrast to 
previously characterised eukaryotic TBPs that exhibit optimal binding at 30˚C (Ge et al., 1996), 
our findings indicate a preference of PfTBP for lower incubation temperatures, with higher 
incubation temperatures most likely affecting the intrinsic properties of the protein.  
3.2.3. PfTBP binds kahrp and Ad2ML promoter regions with similar affinity
In order to further investigate the PfTBP-DNA complexes, Ad2ML or kahrp promoters were 
incubated with increasing amounts of PfTBP in the absence of competitor DNA. With 9ng of 
PfTBP both promoters were quantitatively bound and the PfTBP-promoter complexes were seen 
migrating directly above the free probe (Fig. 10). No significant difference in quantity or 
mobility was observed between the PfTBP nucleoprotein complexes with kahrp and Ad2ML 
promoters. As seen on the lower exposure (Fig. 10, 1s expo), increase of PfTBP resulted in 
diminishing of the probe, indicative of low-affinity binding across the target DNA. Interestingly, 
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the relative mobility of the PfTBP-DNA decreased with increasing amounts of PfTBP. This 
could indicate successive binding of PfTBP to multiple sites, determined by PfTBP 
concentration. 
3.3.  Expression and purification of 6His:PfTFIIB:GST 
3.3.1. Cloning of 6His:PfTFIIB:GST 
 
PfTFIIB has been cloned previously within our research group and a potential C-terminal 
degradation upon recombinant expression was observed. To ensure the purification of full-length 
PfTFIIB, an expression vector for N-terminally 6His-tagged and C-terminally GST-tagged full-
length PfTFIIB was constructed. This was achieved by construction of an intermediate vector by 
insertion of a GST ORF into a pET11d-6His plasmid, and subsequent ligation of PfTFIIB ORF 
into the constructed pET11d-6His-GST vector frame. 
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Figure 10. PfTBP has similar binding activity on kahrp and Ad2ML promoters. 
Analysis of PfTBP binding to kahrp and Ad2ML promoters by Mg2+agarose EMSA. Binding 
reactions (10µl) contained 5fmol 282bp kahrp or 297bp Ad2ML probe and 0.9ng (lanes 2,7), 
2.7ng (lanes 3,8), 9ng (lanes 4,9) or 27ng (lanes 5,10) of 6His:PfTBPc. Protein-DNA complexes 
were resolved in 1.4% agarose gels (0.5xTBE; 5mM MgCl2). The two panels indicate 1s and 30s 
exposure of the same experiment. 
The open reading frame for PfTFIIB was obtained by PCR amplification of cDNA phage library 
MRA-296. The MRA-296 cDNA phage library is derived from mRNA of blood stage cultures of 
Plasmodium falciparum clone 3D7 16 hours post-synchronisation, corresponding to the late-ring 
stage of the parasite (Chakrabarti et al., 1994). 
The detailed cloning protocol is provided in Chapter 2.1 and the plasmid map for pET11d-6His-
PfTFIIB-GST can be found in Appendix A. 
3.3.2. IPTG-induced expression of 6His:PfTFIIB:GST inhibits cell growth 
Previous studies within our research group have linked IPTG-induction of the heterologous 
expression of P. falciparum proteins to the inhibition of host cell growth. In order to assess the 
effect of IPTG-induced expression of 6His:PfTFIIB:GST on the host cells, two independent 
expression cultures were set up. E. coli BL21-codonPlus (DE3)-RIL cells were transformed with 
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Figure  11.  IPTG-induced  6His:PfTFIIB:GST expression  in  E.coli  BL21(DE3)-RIL cells 
leads to growth inhibition.
Cell densities were measured spectrophotometrically at a wavelength of 600nm and plotted 
against time. Expression cultures were induced with 1mM IPTG after 2 hours of growth. Growth 
of the induced (dark grey) and uninduced (light grey) cultures was compared. 
pET11d-6His-PfTFIIB-GST expression vector and grown in liquid media at 37°C. The cell 
density was measured spectrophotometrically throughout initial growth phases and, at log-phase 
(OD600nm= ~ 0.5), one of the two cultures was induced with 1mM IPTG. Cell growth was 
continuously monitored post-induction and cells harvested at stationary phase. IPTG-induced 
cultures exhibited a reduction in growth, observable immediately post-induction with IPTG (Fig. 
11). The detrimental effect to cell growth could be due to PfTFIIB toxicity to the cells and thus 
the expression levels of 6His:PfTFIIB:GST in induced and uninduced cultures were investigated. 
3.3.3. Optimal 6His:PfTFIIB:GST expression is achieved from uninduced cultures 
In order to assess the expression of 6His:PfTFIIB:GST in induced and uninduced cultures, the 
expressed proteins were purified via the 6His-tag using Ni-NTA magnetic beads or via the GST-
tag using GSH-agarose, as described in Chapter 2.2. A 70kDa band, which is the expected size of 
6His:PfTFIIB:GST, was enriched with both affinity purification methods, providing strong 
evidence for recombinant 6His:PfTFIIB:GST expression (Fig. 12). Notably, 6His:PfTFIIB:GST 
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Figure 12. 6His:PfTFIIB:GST is expressed in induced and uninduced cultures.
SDS PAGE analysis of 6His:PfTFIIB:GST expression in induced and uninduced cultures. 
Cleared lysate (input, IN) of induced and uninduced cultures was passed over Ni-NTA beads or 
GSH-beads. Eluates (ENI and EGSH, respectively; 10µl [=1/5th total elution volume]) were 
resolved by 12% SDS PAGE. M: Molecular weight marker (BioRad Precision Plus All Blue). 
The relative position of protein MW standards is indicated.
was effectively expressed in uninduced cultures, where also more cell mass could be harvested. 
It seems, in the absence of IPTG, the basal level of T7 polymerase expression induces PfTFIIB 
expression at levels that are not toxic to the host cell and thus enables the generation of more cell 
mass compared to the IPTG-induced cultures. These observations are consistent with previous 
findings within our research group (Steven Bing, unpublished observations). As sufficient 
expression and higher cell mass was obtained from uninduced cultures, it was deemed more 
efficient and established as a standard for PfTFIIB expression.  
3.3.4. Sequential affinity-purification of 6His:PfTFIIB:GST 
 
Further purification of 6His:PfTFIIB:GST was attempted using Ni-NTA and GSH agarose in a 
sequential manner, as described in Chapter 2.2. Two dominant bands migrating at 70kDa and 
around 25kDa were seen after the purification with GSH agarose (Fig. 13). The band migrating 
around 70kDa, the expected size of 6His:PfTFIIB:GST, remained prominent after Ni-NTA 
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Figure 13. Purification of 6His:PfTFIIB:GST by sequential affinity chromatography. 
A. SDS PAGE analysis of purified 6His:PfTFIIB:GST fractions. Cleared lysate (input, IN) of 
uninduced cultures was purified on GSH-agarose, followed by Ni-NTA agarose. Eluates (GSH 
and NI, respectively, 10µl [=1/300th total elution volume]) were resolved by 12% SDS PAGE. 
The relative position of protein MW standards (BioRad Precision Plus All Blue), 
6His:PfTFIIB:GST and GST-tag is indicated. 
B. Immunoblot analysis of purified 6His:PfTFIIB:GST. 6His:PfTFIIB:GST (40ng) was 
resolved by 12% SDS PAGE, transferred to a PVDF membrane and probed with a 1:1000 
dilution of affinity-purified α-PfTFIIB antibody. X-ray film exposure time: 10s. Coomassie-
stained gel that corresponds to the immunoblot is indicated. 
purification. GST-tag has a molecular weight of 26kDa, corresponding to the prominent band 
seen after GSH-agarose purification. The presence of free GST-tag is commonly reported in 
GST-fusion protein expression systems and could be the result of intracellular proteolytic 
degradation events that lead to premature excision of the tag from the fusion protein (Harper and 
Speicher, 2011).  
6His:PfTFIIB:GST fusion protein migrated in SDS PAGE gels as a doublet of bands and 
analysis with purified α-PfTFIIB (identifies residues 353-367) confirmed the immunoreactivity 
of both bands of the doublet (Fig. 13B). This feature of PfTFIIB is discussed further in Chapter 
3.4.3. In addition to 6His:PfTFIIB:GST, the purified α-PfTFIIB antibody detected low molecular 
weight protein bands in the preparation, indicating the presence of PfTFIIB proteolytic 
breakdowns. 
The 6His:PfTFIIB:GST preparation presented in Figure 13B was utilised in subsequent DNA 
binding assays.  
3.4.  Expression and purification of 6His:PfTFIIB, 6His:PfTFIIB∆37 & 
6His:PfTFIIB∆140
 
Initial investigation into PfTBP-PfTFIIB complex formation in EMSA showed PfTBP-
independent DNA-binding activity of PfTFIIB. In order to determine the regions of PfTFIIB 
harbouring DNA-binding activity, two PfTFIIB deletion mutants were generated. PfTFIIB is 
predicted to harbour a highly basic (pI>11.5) 37-residue N-terminal region. Structural 
predictions indicate this region to be a largely unstructured non-conserved region, with some 
potential for α-helix formation (Steven Bing, unpublished observations). This region could 
contribute to non-specific DNA binding by interacting with the negatively charged DNA 
backbone, however, specific interactions via alternative DNA-binding motifs cannot be 
excluded. The C-terminal domain is predicted to contain two cyclin-like repeats (Nikolov et al., 
1995) which in other eukaryotes harbour a helix-turn-helix motif, that is involved in DNA 
sequence recognition (Lagrange et al., 1998). With these features in mind, deletion mutants 
lacking the N-terminal highly basic 37 residues (termed PfTFIIB∆37) or the entire N-terminus 
(termed PfTFIIB∆140) were generated.  
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3.4.1. Cloning of 6His:PfTFIIB, 6His:PfTFIIB∆37 & 6His:PfTFIIB∆140 
 
The open reading frames of full length PfTFIIB and deletion mutants lacking 37 and 140 and N-
terminal amino acids (PfTFIIB∆37 and PfTFIIB∆140, respectively), were amplified by PCR 
from the previously constructed 6His:PfTFIIB:GST vector and ligated into pET11d-6His vector. 
Primer sequences and detailed cloning protocol are provided in Chapter 2.1. Detailed 
pET11d-6His-PfTFIIB, pET11d-6His-PfTFIIB∆37 and pET11d-6His-PfTFIIB∆140 plasmid 
maps can be found in Appendix A. 
3.4.2. Expression of 6His:PfTFIIB, 6His:PfTFIIB∆37 & 6His:PfTFIIB∆140 
As discussed in Chapter 3.3.3, 6His:PfTFIIB:GST expression was achieved by auto-induction 
from glucose-containing media. However, highly variable results were obtained with 1%(w/v) 
glucose in expression media of 6His-tagged PfTFIIB variants (data not shown). These variable 
results could be explained by variations in glucose concentration and/or quality, affecting the 
dynamics of cellular metabolism or inducing a lag in the uptake of glucose from the media, 
resulting in aberrant expression of PfTFIIB. For these reasons, glucose was used for culturing 
plates and starter culture media, however it was omitted from expression culture media. Briefly, 
initial cell mass was generated by an overnight starter culture with media containing 1%(w/v) 
glucose. Expression media lacking glucose was inoculated with starter culture (ratio 1:20 (v/v)) 
and incubated at 37˚C for 5 hours. Expression cultures were not induced with IPTG. A detailed 
expression protocol is provided in Chapter 2.2. 
3.4.3. Nickel affinity purification of 6His:PfTFIIB, 6His:PfTFIIB∆37 & 
6His:PfTFIIB∆140 
Full length 6His:PfTFIIB and the mutants 6His:PfTFIIB∆37 and 6His:PfTFIIB∆140 were 
purified via the 6His-tag using Ni-NTA agarose resins. Consistent with the results obtained after 
the purification of 6His:PfTFIIB:GST, a doublet band at 44kDa separated by approximately 
2kDa was observed in the 6His:PfTFIIB elution (Fig. 14A). Immunoblot analysis  with purified 
α-PfTFIIB antibody, that identifies the C-terminal region (residues 353-367) of PfTFIIB, 
confirmed the doublet bands as PfTFIIB. Upon purification of the deletion mutant 
6His:PfTFIIB∆37, a similar doublet was observed migrating around 40-42kDa (Fig. 14B). As 
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Figure  14.  Nickel-affinity  purification  of  full  length  PfTFIIB  and  PfTFIIB  deletion 
mutants.
SDS PAGE and immunoblot analysis of Ni-NTA agarose purified 6His:PfTFIIB (A), 
6His:PfTFIIB∆37 (B) 6His:PfTFIIB∆140 (C).  
Equivalent amounts of cleared lysate input (IN), Ni-NTA flowthrough (FT) and 10µl (1/60th 
of total elution volume) of Ni-NTA agarose elution (E) was resolved by 12% SDS PAGE. 
6His:PfTFIIB (5ng), 6His:PfTFIIB∆140 (5ng) and 6His:PfTFIIB∆37 (2ng) were resolved by 
12% SDS PAGE, transferred to a PVDF membrane and probed with a 1:1000 dilution of 
affinity-purified α-PfTFIIB antibody. X-ray film exposure time: 10s. M: Molecular weight 
marker (BioRad Precision Plus All Blue). The relative position of protein MW standards and 
purified recombinant proteins are indicated.
seen in Figure 14C, a single 28kDa band was enriched following Ni-NTA purification of 
6His:PfTFIIB∆140, which lacks the entire N-terminus of PfTFIIB. The presence of the doublet 
band in all PfTFIIB variants except the PfTFIIB∆140, suggests that the banding pattern observed 
could be determined by the zinc-finger structure.  
3.4.4. Further purification of 6His:PfTFIIB variants using ion exchange 
chromatography  
In order to achieve sufficient purity for the usage of PfTFIIB variants in electrophoretic mobility 
shift assays, further purification of the 6His:PfTFIIB was attempted. 6His:PfTFIIB, 
6His:PfTFIIB∆37 and 6His:PfTFIIB∆140, with calculated pIs of 9.82, 9.37 and 9.82, 
respectively, are expected to bind to strong cation exchange resins. Furthermore, E.coli proteins 
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Figure 15. Ion exchange chromatography purification of full length PfTFIIB.
Overall purification scheme of PfTFIIB variants (A) and SDS PAGE analysis of full length 
PfTFIIB purification with SP-Sepharose (B).  
Cleared lysate was purified by Ni-NTA agarose, eluates adjusted to BC-100 (100mM KCl), 
and subjected to purification with SP-Sepharose. Equivalent amount of pooled Ni-NTA agarose 
eluate before (NI) and after buffer exchange to 100mM KCl (BE), SP-Sepharose flowthrough 
(SP) and 10µl (1/200th of the total elution volume) of the elution fractions (lanes 6-8: 100mM 
KCl; 9-11: 350mM KCl; 12-15: 500mM KCl) were resolved by 12% SDS PAGE. M: 
Molecular weight marker (BioRad Precision Plus All Blue). The relative position of protein 
MW standards and purified recombinant proteins are indicated. 
that commonly contaminate Ni-NTA purified proteins, have a pI below 7 (Bolanos-Garcia and 
Davies, 2006). Pilot purification was attempted using SP-Sepharose Fast Flow (Sigma-Aldrich). 
6His:PfTFIIB was bound to the resin at 100mM KCl and eluted stepwise with increasing KCl 
concentrations (Fig. 15A). Two prominent contaminants present in the 6His:PfTFIIB preparation 
migrating at around 70kDa and 25kDa did not bind the cation exchange resin and were removed 
in the flowthrough (Fig. 15B, lane 4). The low molecular weight band migrating at around 
15kDa is likely to correspond to lysozyme. With a pI of ~11, lysozyme is expected to bind to SP-
Sepharose under the conditions. As seen in Figure 15B, 6His:PfTFIIB bound quantitatively to SP 
Sepharose under the conditions. With stepwise elution using increasing KCl concentrations, 
lysozyme was removed at 350mM KCl, followed by 6His:PfTFIIB elution at 500mM KCl. All 
contaminants visible by Coomassie staining were effectively separated from 6His:PfTFIIB using 
this purification scheme and similar purity was achieved for 6His:PfTFIIB∆37 and 
6His:PfTFIIB∆140. The purified 6His:PfTFIIB, 6His:PfTFIIB∆37 and 6His:PfTFIIB∆140 
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Figure 16. Purified PfTFIIB variants used in EMSAs. 
SDS PAGE analysis of purified 6His:PfTFIIB, 6His:PfTFIIB∆37 and 6His:PfTFIIB∆140. 
SDS PAGE analysis of full length 6His:PfTFIIB (PfTFIIB), 6His:PfTFIIB∆37 (∆37) and 
6His:PfTFIIB∆140 (∆140), purified by Ni-NTA affinity chromatography, followed by ion 
exchange chromatography on SP-Sepharose. Pooled 500mM KCl SP-Sepharose elutions (1, 2 
and 4µl) and 20, 40, 80, 100ng of BSA (lanes 11-14, respectively) were resolved by 12% SDS 
PAGE. Note that BSA was added to all elution fractions at a concentration of 100ng/µl. M: 
Molecular weight marker (NEB Colour Pertained Protein Standard). The relative position of 
protein MW standards and purified recombinant proteins are indicated. 
preparations were quantified by comparison to BSA standards in SDS PAGE (Fig. 16) and used 
in subsequent DNA binding assays.  
3.5.  Initial characterisation of PfTFIIB in DNA-binding assays
3.5.1. PfTFIIB binds immobilised kahrp promoter in the absence of PfTBP 
 
The DNA-binding potential of full length and mutant PfTFIIBs was first assessed in 
immobilised template assays (ITAs). For that purpose, 40ng of each PfTFIIB variant was 
incubated in standard transcription buffer containing 1pmol of immobilised kahrp probe or 
equivalent amount of free beads. Strikingly, the full length 6His:PfTFIIB as well as the 
6His:PfTFIIB∆37 deletion mutant bound nearly quantitatively to the immobilised DNA under 
the conditions, whereas no binding was observed to the free beads (Figure 17B, compare lanes  2 
and 3). Hence, the deletion of 37 N-terminal residues does not significantly alter the DNA-
binding activity of PfTFIIB in this assay. However, only about 50% of the input 
6His:PfTFIIB∆140 bound the DNA probe. These results indicate that the C-terminal region of 
PfTFIIB possesses PfTBP-independent DNA-binding activity, which is further enhanced 
minimally by the presence of the N-terminal region lacking the 37-residues.  
Challenges with poly(dG-dC) competitor completely disrupted the binding of 6His:PfTFIIB as 
well as 6His:PfTFIIB∆140 when 8-fold molar excess of competitor was present (Fig. 17C). The 
binding specificity of these regions cannot be determined at this stage, as this assay does not 
discriminate between specific and non-specific binding.  
3.5.2. PfTFIIB binds P. falciparum kahrp and var promoter regions in PAGE EMSA 
 
Next, PfTBP-independent PfTFIIB DNA-binding was investigated in EMSA conditions. In 
contrast to PfTBP and 6His:PfTFIIB:GST, PfTFIIB-DNA complexes with the 6His-tagged 
PfTFIIB variants could be resolved in polyacrylamide gel EMSAs. Having previously 
encountered extreme probe retention using PfTBP and PfTFIIB in conjunction with 282bp 
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Figure 17. PfTBP-independent DNA-binding activity of full length PfTFIIB and PfTFIIB 
deletion mutants.
 A. Schematic of the PfTFIIB variants used in this study. 
 B. Immunoblot analysis of PfTFIIB variants binding to immobilised kahrp promoter. DNA-
binding reactions (40µl) contained 40ng 6His:PfTFIIB, 6His:PfTFIIB∆37 or 
6His:PfTFIIB∆140 and 1pmol of immobilised kahrp promoter DNA (+) or free beads (-), as 
indicated. Equivalent amounts of unbound (UB; lane 3) and bound fractions (B; lane 2) were 
analysed by immunoblot with α-PfTFIIB antibody (1:1000). X-ray film exposure: 30s. 
 C. Immunoblot analysis of poly(dG-dC) competition of PfTFIIB binding to kahrp promoter. 
DNA-binding reactions (40µl) contained 40ng 6His:PfTFIIB or 6His:PfTFIIB∆140 and 1pmol 
of immobilised kahrp promoter DNA, 1µg (lane 2), 1.25µg (lane 3), 1.5µg (lane 4) of 
poly(dG-dC). Bound fractions (1/2th of total elution volume) were analysed by immunoblot 
with affinity-purified α-PfTFIIB antibody (1:1000). X-ray film exposure: 5min. 
experimental probes, a 60bp region of the kahrp probe, as well as a 60bp upstream region of the 
highly variable (var) genes were used as an alternative (see Chapter 2.5). On longer probes, it 
seemed likely that the retention of protein-DNA complexes was caused by multiple binding 
events, therefore, the smaller probe size was expected to allow the complexed DNA to enter the 
gel matrix.  
As seen from Figure 18, 6His:PfTFIIB∆140 and 6His:PfTFIIB∆37 formed stable complexes 
with the 60bp var as well as the kahrp probe, in the presence of 100ng poly(dG-dC) competitor 
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Figure  18.  PfTBP-independent  binding  of  PfTFIIB∆37  and  PfTFIIB∆140  in 
polyacrylamide EMSA. 
A. Analysis of PfTFIIB binding to a 60bp var promoter by PAGE EMSA. 
10µl binding reactions contained 2fmol 60bp var promoter, 100ng poly(dG-dC) and 20ng 
6His:PfTFIIB, 20ng 6His:PfTFIIB∆140 or 10ng 6His:PfTFIIB∆37. Protein-DNA complexes 
were resolved in 5% (29:1) native polyacrylamide gel, transferred to a nitrocellulose 
membrane and visualised by chemiluminescent detection. X-ray film exposure: 30min. Lanes 
1-4 originate from the same gel.  
B. Analysis of PfTFIIB binding to the kahrp promoter by PAGE EMSA. 
10µl binding reactions contained 2fmol 60bp kahrp promoter, 100ng poly(dG-dC) and 10ng/
20ng 6His:PfTFIIB∆37 (lanes 2,3, respectively) or 20/40ng 6His:PfTFIIB∆140 (lanes 4,5, 
respectively). Protein-DNA complexes were resolved in 5% (37:1) native polyacrylamide gel, 
transferred to a nitrocellulose membrane and visualised chemiluminescent detection. X-ray 
film exposure: 3hr.
DNA. Interestingly, PfTFIIB deletion mutants formed two distinct shifts with the var probe, 
whereas a single complex was seen with the kahrp probe. This might indicate the presence of 
two unique binding sites or formation of two structurally distinct complexes on the var probe. At 
equimolar quantities of 6His:PfTFIIB∆140 and 6His:PfTFIIB∆37, significantly higher binding 
activity with ∆37 was observed, consistent with the findings in ITAs (data now shown). No 
complexes were observed with full length PfTFIIB (Fig. 18A). Unstable protein-DNA 
complexes and non-specific DNA binding are known to be sensitive to electrophoresis 
conditions. The N-terminal basic region of full length PfTFIIB might contribute to non-specific 
binding of DNA, or is interacting extensively with the competitor DNA, resulting in the inability 
to form stable complexes with the target DNA. These findings were consistently reproduced in 
subsequent PAGE EMSAs and provide further evidence for the intrinsic DNA-binding activity 
of PfTFIIB under specified conditions. 
3.5.3. Temperature dependence of PfTFIIB DNA-binding 
In order to test the effect of incubation temperature on PfTFIIB-DNA complex formation, 
6His:PfTFIIB∆140 binding reactions were incubated on ice, at room temperature, and at 30˚C in 
PAGE EMSA. 6His:PfTFIIB∆140-kahrp complex was seen with binding reactions incubated on 
ice or room temperature, whereas very little complex was detected when incubation was carried 
out at 30˚C (Fig. 19A, compare lanes 2-4). Interestingly, the total amount of probe detected 
appeared to be in direct correlation with the incubation temperature. High incubation 
temperature could lead to partial protein denaturation, and unspecific binding and aggregation 
could cause the complete inability of the protein-DNA complexes to enter the gel matrix in 
polyacrylamide EMSAs.  
The temperature-dependence of PfTFIIB DNA-binding was further assessed in agarose EMSA 
conditions. For that purpose, 80ng of 6His:PfTFIIB∆140 was incubated with kahrp promoter at 
30˚C and on ice. PfTFIIB-DNA complex was seen migrating directly above the free probe, with 
approximately 2-fold more probe bound upon incubation on ice compared to 30˚C (Fig. 19B, 
compare lanes 2 and 5). In order to assess the stability of the complexes, poly(dG-dC) 
competitor DNA was included in the binding reactions. In the presence of 100ng poly(dG-dC) 
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competitor DNA, complexes formed at 30˚C were completely disrupted, whereas complex 
formation was still detectable after incubation on ice (Fig. 19B, compare lanes 3 and 6). Taken 
together, these results indicate a higher DNA-binding activity of PfTFIIB and higher stability of 
the resulting complexes at a low temperature, consistent with PfTBP findings (see Chapter 
3.2.2). In addition, these results further confirm DNA-binding activity of PfTFIIB, that can be 
resolved in both agarose and polyacrylamide EMSAs. 
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Figure 19. PfTFIIB-DNA complex formation is temperature-dependent.
A. Analysis of PfTFIIB∆140 binding to the kahrp promoter by native PAGE EMSA. 
Binding reaction (10µl) contained 2fmol 60bp kahrp probe, 120ng 6His:PfTFIIB∆140 (∆140) 
and 50ng poly(dG-dC). Binding reactions were incubated at 30 ̊C, room temperature (RT) or 
on ice (4 ̊ C) for 45min, as indicated. Protein-DNA complexes were resolved in 5% (37:1) 
native polyacrylamide gel, transferred to a nitrocellulose membrane and visualised by 
chemiluminescent detection. X-ray film exposure: 2hr. 
B. Analysis of PfTFIIB∆140 binding to the kahrp promoter by Mg2+agarose EMSA. 
Binding reaction (10µl) contained 20fmol 282bp kahrp probe, 80ng 6His:PfTFIIB∆140 and 
100ng (lanes 3,6) or 400ng (lanes 4,7) of poly(dG-dC). Binding reactions were incubated at 30 
̊C or on ice (4 ̊ C) for 45min, as indicated. Protein-DNA complexes were resolved in 1.4% 
agarose gels (0.5xTBE; 5mM MgCl2), vacuum-transferred to a nitrocellulose membrane and 
visualised by chemiluminescent detection. X-ray film exposure: 2s.
3.5.4. PfTFIIB N-terminus contributes to the PfTBP-independent DNA-binding activity  
 
Next, the binding activities of the full length PfTFIIB and PfTFIIB deletion mutants were 
compared. The relative protein concentration in each preparation was normalised by SDS PAGE 
and immunoblot (Fig. 16, data not shown). Equivalent molar amounts of full length PfTFIIB and 
PfTFIIB deletion mutants were incubated with kahrp promoter in the absence of competitor 
DNA. The probe was quantitatively bound by 11nM of full length 6His:PfTFIIB, whereas no 
significant binding was observed with 6His:PfTFIIB∆37 or 6His:PfTFIIB∆140 at the same 
molar concentration (Fig. 20 compare lanes 3, 6 and 9). 23nM of 6His:PfTFIIB∆37 and 71nM of 
6His:PfTFIIB∆140 was minimally required for the detection of DNA-binding (Fig. 20, lanes 7, 
11). With the double affinity chromatography purified full length 6His:PfTFIIB:GST, similar 
complexes to those formed with 6His:PfTFIIB were seen, with the probe quantitatively bound at 
similar molar concentrations. Since the DNA-binding activity of the full length PfTFIIB is 
clearly higher than that of the deletion mutants’, it seems evident that the 37-residue N-terminal 
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Figure 20. PfTFIIB DNA-binding is modulated by the N-terminal 37-residue region. 
Analysis of the binding of full length PfTFIIB and PfTFIIB deletion mutants to the kahrp 
promoter by Mg2+ agarose EMSA.10µl binding reactions contained 5fmol 282bp kahrp probe, 
4.5nM, 11nM, 23nM 6His:PfTFIIB (lanes 2-4, respectively), 6His:PfTFIIB∆37 (lanes 5-7, 
respectively), 6His:PfTFIIB∆140 (lanes 8-10) and 6His:PfTFIIB:GST (lanes 13-15, 
respectively). 6His:PfTFIIB∆140 was further titrated up to 36nM and 71nM (lanes 11,12, 
respectively). Protein-DNA complexes were resolved in 1.4% agarose gels (0.5xTBE; 5mM 
MgCl2), vacuum-transferred to a nitrocellulose membrane and visualised by chemiluminescent 
detection. The two panels indicate 1s and 1min exposure of the same experiment. 
region contributes to PfTFIIB DNA-binding to a large extent in this assay. The N-terminal 
region lacking the 37-residues and the C-terminal core domain also have DNA-binding 
properties under the conditions, albeit to a lesser extent. Taken together, these results are 
consistent with the binding activity observed in ITAs, and further confirm the intrinsic binding 
activity of PfTFIIB.  
3.5.5. PfTFIIB has sequence preference for A/T-rich sequences  
The PfTBP-independent DNA-binding activity of PfTFIIB could imply a specific function of 
PfTFIIB, such as promoter recognition. Investigation of DNA sequence preference could provide 
the first evidence for specific DNA-binding of PfTFIIB. Initial assessment of sequence 
preference was carried out by comparison of PfTFIIB binding to  the P. falciparum kahrp 
promoter or the model promoter Ad2ML. The basepair composition differs radically between the 
two promoters, with guanine-cytosine-(G/C-) content of the kahrp promoter sequence being only 
23% compared to the 61% of the Ad2ML promoter.  
Gradual complex formation with Ad2ML was observed and the probe was quantitatively bound 
only at the highest amount of PfTFIIB (Fig. 21, lanes 6-8). However, the kahrp promoter was 
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Figure 21. Analysis of PfTFIIB binding to the kahrp and Ad2ML promoters by Mg2+agarose 
EMSA.
Binding reactions (10µl) contained 5fmol 282bp kahrp or Ad2ML probe and 10, 20, 40ng of 
6His:PfTFIIB:GST (lanes 2-4, 6-8). Protein-DNA complexes were resolved in 1.4% agarose gels 
(0.5xTBE; 5mM MgCl2), vacuum-transferred to a nitrocellulose membrane and visualised by 
chemiluminescent detection. X-ray film exposure: 1s.
quantitatively shifted with the lowest amount of PfTFIIB (Fig. 21, lane 2). Further mobility shift 
of the probe upon increasing the PfTFIIB concentration was observed with the kahrp promoter 
only, indicating binding at multiple locations with low affinity. These differences suggest that 
PfTFIIB binds A/T-rich sequences with higher affinity. 
To further investigate if PfTFIIB has a preference for a consensus TATA-motif, PfTFIIB-kahrp 
complexes were challenged with up to 20-fold molar excess of unlabelled 126bp TATA-box 
containing, or TATA-less mouse TdT (mTdT) promoter. Interestingly, with 2-fold molar excess 
of the TATA-containing competitor, the PfTFIIB-DNA complex was disrupted and an alternative 
complex appeared, which migrated between the free probe and the original PfTFIIB-kahrp 
complex (Fig. 22, compare lanes 2 and 15). Increasing amounts of the TATA-containing 
competitor did not further affect the complex formation (Fig. 22, compare lanes 16, 17). A 
similar intermediate complex was seen with the TATA-less competitor only at 20-fold excess of 
the competitor over the kahrp probe (Fig. 22, compare lanes 2, 11 and 14). Free probe was not 
fully recovered with either competitor at these concentrations. It seems, PfTFIIB binds the 
282bp kahrp promoter at multiple locations with different affinity, and the binding of PfTFIIB to 
some of those locations is more sensitive to the TATA-containing sequence than the TATA-less 
sequence. Further competition experiments are needed to confirm this finding. 
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Figure 22. PfTFIIB binds preferentially A/T-rich sequences. 
PfTFIIB DNA-binding template competition analysis by Mg2+ agarose EMSA. 
Binding reactions (10µl) contained 5fmol 282bp kahrp probe, 20ng 6His:PfTFIIB:GST, 2,5,10 
or 20x molar excess of unlabelled 138bp kahrp 5’ region (kahrp A), 157bp kahrp 3’ region 
(kahrp C), TATA-less (∆TATA) or TATA-containing (TATA) mTdT promoters. Protein-DNA 
complexes were resolved in 1.4% agarose gels (0.5xTBE; 5mM MgCl2), vacuum-transferred to 
a nitrocellulose membrane and visualised by chemiluminescent detection. X-ray film exposure: 
10s.
To further identify if a specific region of the kahrp promoter is preferentially bound by PfTFIIB, 
PfTFIIB-kahrp complexes were challenged with up to 20-fold molar excess of unlabelled kahrp 
5’ region spanning nucleotides 1-138 (kahrp A) as well as a 157 bp 3’ region spanning 
nucleotides 125-282 (kahrp C). This approach allows an assessment of the binding of PfTFIIB to 
each half of the 282bp kahrp probe. As seen in Figure 22, free probe was fully recovered with 
20-fold excess of kahrp C (Fig. 22, lane 10) and kahrp A (Fig. 22, lane 6). Further experiments 
confirmed complete disruption with either kahrp competitor at minimally 20-fold molar excess 
(data not shown). 
As free probe was fully recovered only when the complex was challenged with 20X kahrp 
promoter and intermediate complex persisted with the TATA variants, the kahrp promoter either 
harbours a specific binding motif distinct from the consensus in the mTdT probe, or the 
preferred binding of PfTFIIB to kahrp promoter is the result of its overall higher A/T-content. 
3.6.  Cooperative binding of PfTBP and PfTFIIB 
3.6.1. PfTBP recruits PfTFIIB on kahrp and gbp-130 promoter regions 
In eukaryotes, TFIIB interacts with promoter-bound TBP and stabilises the TBP-promoter 
complex. In order to first assess interactions between PfTFIIB and PfTBP, immobilised template 
assays were performed, where PfTBP was incubated in the presence and absence of PfTFIIB and 
immobilised kahrp and gbp-130 promoters. It was previously observed, that PfTFIIB elicits 
extensive DNA-binding activity in ITAs (see Chapter 3.5). In order to detect an effect on 
PfTFIIB promoter-binding in the presence of PfTBP, PfTFIIB DNA-binding was suppressed 
with 1.5µg of poly(dG-dC). As seen in Figure 23A, little to no residual PfTFIIB binding to the 
kahrp promoter was detected at these concentrations of the competitor, consistent with previous 
results (see Fig. 17). 
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Figure 23. PfTBP recruits PfTFIIB to putative P. falciparum promoter regions. 
A. Immunoblot analysis of PfTFIIB binding to immobilised gbp-130 and kahrp promoters in 
the presence of PfTBP. DNA-binding reactions (40µl) contained 40ng 6His:PfTFIIB and 12ng 
(lanes 2,9), 30ng (lanes 3,10), 60ng (lanes 4,11) 6His:PfTBPc, as indicated, 1pmol of 
immobilised kahrp (lanes 1-7) or gbp-130 (lanes 8-13) promoter DNA and 1.5µg of poly(dG-
dC). Bound fractions (1/2th total volume) were analysed by immunoblot with α-PfTBP rabbit 
antisera (1:500) or α-PfTFIIB antibody (1:1000), as indicated. X-ray film exposure: 10min.  
B. Immunoblot analysis of PfTFIIB∆140 binding to immobilised kahrp promoter in the 
presence of PfTBP.  
DNA-binding reactions (40µl) contained 40ng 6His:PfTFIIB∆140 and 12ng (lanes 2,5), 30ng 
(lanes 3,6), 60ng (lanes 4,7) 6His:PfTBPc, as indicated, 1pmol of immobilised kahrp promoter 
DNA and 1.5µg of poly(dG-dC). Bound fractions (1/2th total volume) were analysed by 
immunoblot with α-PfTBP rabbit antisera (1:500) or α-PfTFIIB antibody (1:1000), as 
indicated. X-ray film exposure: 10min. 
As shown in Figure 23A, PfTFIIB binding to kahrp and gbp-130 promoters was significantly 
stimulated by the presence of PfTBP (lower panel, compare lanes 1 and 2, 8 and 10). Increasing 
amounts of PfTBP did not appear to further stimulate PfTFIIB binding. As previously noted 
(Chapter 3.5.1, Fig. 17), the binding activity of PfTFIIB∆140 is at least 2-fold weaker compared 
to full length PfTFIIB, and residual binding to kahrp was nearly undetectable (Fig. 23B, lower 
panel, lane 1). Similarly to full length PfTFIIB, PfTFIIB∆140 binding to the promoter was 
greatly stimulated by the presence of PfTBP (Fig. 23B, lower panel, compare lanes 1 and 3). In 
contrast, PfTBP DNA-binding appeared unaffected by the presence of full length PfTFIIB or 
PfTFIIB∆140 (Fig. 23A compare lanes 5-6 and 2-4, panel B compare lanes 4-7 and 2-4). Taken 
together, these results provide strong evidence for the recruitment of PfTFIIB to the kahrp and 
gbp-130 promoters by PfTBP, even in the presence of high excess of poly(dG-dC) competitor. 
Furthermore, in agreement with previous studies in other eukaryotic systems (Nikolov et al., 
1995), the C-terminal domain of PfTFIIB is sufficient for the recruitment by PfTBP. These 
results clearly indicate specific interactions between the transcription factors, and the potential 
for PfTBP-PfTFIIB-promoter complexes were investigated further in EMSAs.  
3.6.2. Formation of ternary PfTBP-PfTFIIB-promoter complex 
 
 
In eukaryotic model systems, TFIIB stabilisation of the TBP-promoter complex is evident from 
the enhancement of TBP binding to the promoter in the presence of TFIIB, resulting in TBP-
TFIIB-promoter ternary complexes in EMSAs. In order to assess the potential for PfTBP-
PfTFIIB-promoter complex formation in EMSAs, the independent binding of PfTFIIB or PfTBP 
was suppressed by 400ng of poly(dG-dC) competitor DNA. Under these conditions, no 
significant binding of PfTBP to kahrp promoter was seen. Similarly to PfTBP, no significant 
binding of PfTFIIB was observed, with some smearing indicative of residual binding (Fig. 24). 
PfTBP incubation in the presence of PfTFIIB resulted in clear decrease in the probe mobility, 
however the complex could not be fully resolved under these conditions. The majority of 
independent promoter-binding of PfTFIIB∆37 was also abolished under the conditions, as seen 
in Figure 24 (lane 6). However, a distinct complex was observed with PfTBP in the presence of 
PfTFIIB∆37. The clear change in mobility and increased probe binding further indicates that the 
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complex observed is a new unique complex, and not the combined effect of individual 
interactions of PfTFIIB and PfTBP with the promoter. PfTFIIB∆140 in conjunction with PfTBP 
did not induce significant complex formation (data not shown). These results indicate the 
formation of a distinct complex in the presence of both PfTBP and PfTFIIB and are in agreement 
with the known model of TFIIB enhancement of TBP-DNA complex formation. 
Next, the presence of both PfTFIIB and PfTBP in the newly formed complex was determined. 
For that purpose, purified α-PfTBP or α-PfTFIIB antibodies were included in the binding 
reactions. As seen from Figure 25A, addition of α-PfTBP antibody resulted in the complete 
disruption of the PfTBP-PfTFIIB∆37-kahrp complex. This suggests that the binding of the 
antibody to PfTBP obstructs the PfTBP interactions with DNA and/or PfTFIIB and thus 
confirms the presence of PfTBP in the complex. In contrast, addition of α-PfTFIIA antibody 
which was produced and purified under identical conditions did not affect the complex. 
Similarly to α-PfTBP, α-PfTFIIB disrupted the protein-DNA complex, indicating the presence of 
PfTFIIB (Fig. 25B, compare lanes 4, 6). α-PfTBP and α-PfTFIIB did not affect the free probe 
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Figure 24. Distinct complex formation with PfTBP in the presence of PfTFIIB.
Analysis of PfTBP binding to the kahrp promoter in the presence of PfTFIIB by Mg2+ agarose 
EMSA. 
Binding reactions (10µl) contained 5fmol 282bp kahrp probe, 3ng 6His:PfTBP (lanes 2, 4-5, 
7), 40ng 6His:PfTFIIB:GST (lanes 3-4) or 60ng 6His:PfTFIIB∆37 (lanes 6-7), as indicated, 
and 400ng poly(dG-dC). Protein-DNA complexes were resolved in 1.4% agarose gels 
(0.5xTBE; 5mM MgCl2), vacuum-transferred to a nitrocellulose membrane and visualised by 
chemiluminescent detection. X-ray film exposure: 10s.
(Fig. 25A, lane 6; data not shown). Together, these results confirm that both PfTFIIB and PfTBP 
are present in the complex. Taken together, these findings provide strong evidence for the 
formation of a bona fide PfTBP-PfTFIIB-DNA complex on putative P. falciparum promoter 
region. 
3.6.3. Sequence preference of PfTBP-PfTFIIB-promoter complex 
Next, the sequence specificity of the PfTBP-PfTFIIB-kahrp ternary complex was analysed. For 
this purpose, pre-assembled PfTBP-PfTFIIB-kahrp complexes were challenged with 2-20x 
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Figure 25. Assembly of a PfTBP-PfTFIIB-DNA ternary complex on P. falciparum kahrp 
promoter region.
Analysis of PfTBP-PfTFIIB-kahrp complex formation by Mg2+ agarose EMSA. 
A. Binding reactions (10µl) contained 5fmol 282bp kahrp probe, 400ng poly(dG-dC), 12ng 
6His:PfTBPc, 60ng 6His:PfTFIIB∆37 and 1µg α-PfTBP, as indicated. Protein-DNA complexes 
were resolved in 1.4% agarose gels (0.5xTBE; 5mM MgCl2), vacuum-transferred to a 
nitrocellulose membrane and visualised by chemiluminescent detection. X-ray film exposure: 
10s. 
B. Binding reactions (10µl) contained 5fmol 282bp kahrp probe, 400ng poly(dG-dC), 3ng 
6His:PfTBPc, 60ng 6His:PfTFIIB∆37 and 1µg α-PfTFIIA or 200ng α-PfTFIIB, as indicated. 
Protein-DNA complexes were resolved in 1.4% agarose gels (0.5xTBE; 5mM MgCl2), 
vacuum-transferred to a nitrocellulose membrane and visualised by chemiluminescent 
detection. X-ray film exposure: 1min.
molar excess of unlabelled 282bp kahrp, gbp-130 or 297bp Ad2ML promoters. As seen in Figure 
26, the PfTBP-PfTFIIB-kahrp complex decreased in the presence of excess unlabelled kahrp or 
gbp-130 promoters, but remained largely unaffected in the presence of excess Ad2ML promoter. 
Previous findings suggest similar binding affinity of PfTBP to kahrp and Ad2ML promoters 
(Fig. 10), whereas a clear preference towards kahrp promoter was seen with PfTFIIB (Fig. 21). 
Since the PfTBP-PfTFIIB-kahrp complex appeared to be inert towards Ad2ML promoter, it is 
apparent that the sequence specificity of the PfTBP-PfTFIIB-DNA complex in comparison to 
individual PfTBP binding had changed. 
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Figure 26. Sequence specificity of the PfTBP-PfTFIIB-kahrp complex.
PfTBP-PfTFIIB-kahrp template competition analysis by Mg2+ agarose EMSA. 
Binding reactions (10µl) contained 5fmol 282bp kahrp probe, 12ng 6His:PfTBPc, 60ng 
6His:PfTFIIB∆37, 2x (lanes 3, 7, 11), 5x (lanes 4, 8, 12),10x (lanes 5, 9, 13) or 20x (lanes 6, 
10, 14) molar excess of unlabelled 282bp kahrp, gbp-130 or 297bp Ad2ML promoters, as 
indicated. Protein-DNA complexes were resolved in 1.4% agarose gels (0.5xTBE; 5mM 
MgCl2), vacuum-transferred to a nitrocellulose membrane and visualised by chemiluminescent 
detection. X-ray film exposure: 5s.
4. Discussion 
4.1.  Expression and purification of PfTBP
The expression of recombinant Plasmodium proteins is known to be challenging, often resulting 
in the production of truncated proteins or low yield (reviewed in Birkholtz et al., 2008). Adverse 
effects on the host cells upon recombinant expression of plasmodial proteins have been reported 
previously (Vedadi et al., 2007). Consistent with these reports, apparent toxicity of P. falciparum 
proteins upon over-expression in E. coli has consistently been observed within our research 
group, resulting in inhibition of host cell growth. Therefore, recombinant PfTBPc in this study 
was generated from uninduced cultures. Purification of PfTBPc was a multi-step approach using 
Ni-affinity chromatography followed by ion exchange chromatography. Early PfTBPc elution 
fractions from Ni-NTA agarose were found to have lower DNA-binding activity than late 
fractions, potentially due to aggregation of PfTBPc in the early fractions that contained PfTBPc 
at higher concentrations. Higher salt concentrations during Ni-NTA agarose purification 
appeared to alleviate aggregation of PfTBPc, therefore cleared lysate preparation and Ni-NTA 
agarose purification at higher salt concentration (500mM KCl instead of 300mM KCl) could 
streamline the process and eliminate the need for re-purification by Ni-NTA beads. The Ni-
affinity purified PfTBPc bound to strong cation exchange resin as expected at its pI of 9.3, and 
eluted at high salt concentrations. The purity of the resulting PfTBPc preparation was deemed 
sufficient for subsequent characterisation and the protocol established is therefore proposed to 
serve as a standard for PfTBP purification.  
4.2.  Initial characterisation of PfTBP in DNA binding assays
The ultimate goal of this research project is to investigate the DNA-binding characteristics of the 
key protein factors involved in transcription initiation in P. falciparum, in order to identify P. 
falciparum core promoter regions and the DNA elements directing transcription initiation 
complex assembly. The DNA-binding activities of PfTBP and PfTFIIB were investigated using 
two independent approaches - electrophoretic mobility shift assays (EMSAs) and immobilised 
template assays (ITAs). Due to the scarcity of current knowledge about optimal transcription 
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conditions for the parasite, initial assays were set up utilising the conditions of the well-
established human model system (Ge et al., 1996, Malecova et al., 2007).  
From the DNA binding assays, three distinct observations were made regarding the DNA-
binding characteristics of isolated PfTBPc. Firstly, PfTBP forms a fast-migrating complex with 
the tested promoter regions in Mg2+ agarose EMSAs and, upon increasing concentrations, the 
mobility of the complex decreases further. Secondly, PfTBP appears to bind to Ad2ML and 
putative P. falciparum promoters with similar affinity, as observed in ITA and EMSA. Thirdly, 
the stability of the PfTBP-DNA complex is significantly enhanced by lowering the incubation 
temperature.  
In eukaryotes, TBP binding to the TATA box is a two-stage process, where initial TBP binding to 
the TATA box does not affect the target DNA, followed by a slow transition into a fully bent 
complex that is subject to stabilisation by TFIIB and TFIIA (Hoopes et al., 1992, Zhao and Herr, 
2002). The DNA-binding activity of TBP resides in the highly conserved C-terminal domain, 
that is a saddle-shaped molecule consisting of two direct repeats of five β-sheets and two α-
helices (Nikolov et al., 1996). TBP interacts with the DNA minor groove with its concave 
surface, where most notably two phenylalanine (Phe) residues insert into the 5’ and 3’ end of the 
TATA box (F288 and F197 in humans, respectively), inducing a kink in the DNA(Nikolov et al., 
1996). Two additional phenylalanine residues (F305 and F214 in humans) support the inserted 
Phe residues and stabilise the induced kinks (Nikolov et al., 1996). Collectively, these 
interactions induce a severe bend in the DNA of about ~80˚, whereby the bending angle is 
dependent on the depth at which the Phe residues are inserted between the base pairs in the DNA 
(Starr et al., 1995, Nikolov et al., 1996). In electrophoretic mobility shift assays, the mobility of 
protein-DNA complex relative to free DNA is determined by the molecular weight and tertiary 
(or quaternary) structure of the DNA-bound protein(s), as well as the conformation of the DNA. 
DNA bending significantly reduces the mobility of protein-DNA complexes in EMSA gels. 
Therefore, due to the extreme TBP-induced bending of DNA, TBP-DNA complexes are 
unusually slow-migrating (Horikoshi et al., 1990, Maldonado et al., 1990). In contrast, protein-
DNA complexes lacking major distortion in DNA structure are highly mobile in Mg2+ agarose 
EMSAs, and are seen migrating in close proximity to the free probe even when multiple proteins 
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are bound (Lieberman and Berk, 1994, Malecova et al., 2015).  
Interestingly, P. falciparum TBP amino acid sequence analysis shows that one of the two Phe 
residues, that insert between the DNA and are highly conserved between eukaryotic TBPs, is 
replaced by isoleucine (Ile183) (Thomas Oelgeschläger, unpublished observations). Mutations of 
single or both Phe residues of the two Phe pairs have been shown to render TBP incapable of 
forming stable TBP-DNA complexes in eukaryotic and archaeal systems (Klejman et al., 2005, 
Gietl et al., 2014). The results in this study reveal a fast-migrating PfTBP-DNA complex with P. 
falciparum and Ad2ML promoters, observable directly above the free probe. Considering the 
absence of one kink-inducing Phe residue in P. falciparum TBP and the appearance of a fast-
migrating PfTBP-DNA complex, it seems likely, that PfTBP does not induce the degree of 
DNA-bending observed with other eukaryotes.  
TBP has a relatively low DNA-binding specificity compared to typical DNA-binding 
transcription regulators (Coleman and Pugh, 1995, Weideman et al., 1997) and can form 
complexes with variable TATA sequences that bear little resemblance to the optimal TATA-motif 
(5︎-TATATAAG-3︎) (Buratowski et al., 1989, Wong and Bateman, 1994). We observed a PfTBP 
concentration-dependent decrease in the mobility of the DNA probe that can be explained by 
successive binding of multiple PfTBP molecules to lower affinity binding sites at higher protein 
concentrations. Thus, PfTBP seems to bind at multiple locations within P. falciparum putative 
kahrp promoter regions, as well as the adenovirus 2 major late model promoter.   
Seminal studies of human TFIID binding to DNA reported an increased binding of TBP to TATA 
sequences at 30˚C in comparison to 4˚C (Lee et al., 1992). These conditions are thought to be 
thermodynamically favourable for DNA bending during TBP-DNA complex formation (Petri et 
al., 1995). An incubation temperature of 30˚C has since become the standard temperature in 
DNA binding and transcription assays of human, Drosophila and yeast systems (Thomas and 
Chiang, 2006). Despite the preferred incubation temperature of 30˚C of wild-type yeast TBP 
(yTBP), yTBP C-terminal domain forms stable complexes with DNA when incubated at 0˚C or 
4˚C (Lieberman et al., 1991, Lee et al., 1992, Kuddus and Schmidt, 1993). Similarly to yeast, 
PfTBP core domain formed stable complexes at lower temperatures. However, in contrast to 
yTBP, PfTBP DNA-binding was found to be destabilised by higher incubation temperatures. 
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This feature of PfTBPc was not investigated further in this MSc project. The potential need for 
optimising binding conditions was anticipated and it is possible that further adjustments of 
reaction conditions could significantly affect the outcome of future DNA-binding experiments 
with P. falciparum proteins.  
4.3.  Discrepancies with findings reported by Ruvalcaba-Salazar et al. (2005).
The initial characterisation of P. falciparum TBP in this study has revealed several features of 
PfTBP that were consistently observed throughout the study and evident from highly 
reproducible experiments. Firstly, recombinant PfTBP expression is achieved from highly 
specialised cells adapted for the bacterial expression of proteins from AT-rich genomes and 
IPTG-induction was found to inhibit cell growth. Thus, in agreement with previous studies on 
recombinant plasmodial protein expression, PfTBP was found to be extremely toxic to the host 
cells, resulting in low yield of soluble PfTBP in induced cultures. Secondly, despite 
comprehensive optimisation of native PAGE EMSA conditions, PfTBP-DNA complexes could 
not be resolved in this assay. Thirdly, we show extensive DNA-binding activity of PfTBP in ITA 
and Mg2+ agarose EMSAs and provide evidence for PfTBP DNA-binding at multiple locations 
across the tested DNA probes. Lastly, our results suggest similar binding affinity of PfTBP on 
putative P. falciparum promoter regions as well as Ad2ML promoter. 
The study conducted by Ruvalcaba-Salazar et al. (2005) reports high expression levels of 
recombinant PfTBP core domain from IPTG-induced cultures, using E.coli DH5α cells. 
Ruvalcaba-Salazar et al. (2005) demonstrate specific PfTBP-DNA complex formation in native 
PAGE EMSAs, even at very high (up to 250ng) concentrations of PfTBP. Furthermore, a distinct 
TATA-box at position -81 on the putative kahrp promoter and a TATA-like sequence at position 
-186 on the gbp-130 promoter as exclusive PfTBP binding sites on the promoters were identified 
using native PAGE EMSAs and DNAse I footprinting assays. These findings were validated in 
vivo by ChIP assays, utilising polyclonal antibody against human TBP, that was shown to 
identify PfTBP from nuclear Plasmodium extracts.  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Several of these results reported by Ruvalcaba-Salazar et al. (2005) are incompatible with our 
findings. The high levels of PfTBP expression achieved from IPTG-induced cultures clearly 
contradict our findings, where IPTG-induced PfTBP expression inhibited cell growth and caused 
premature cell death. It is therefore surprising, that the recombinant expression of PfTBP was 
achieved in E.coli DH5α cells which are commonly used for routine cloning applications and are 
not adapted for the expression of P. falciparum genes with the extreme codon bias. Remarkably, 
amid the abundance of potential TATA-motifs in the gbp-130 and kahrp promoter regions, 
Ruvalcaba-Salazar et al. (2005) identified specific TATA-motifs using native PAGE EMSAs. 
Our findings in Mg2+ agarose EMSAs indicate PfTBP binding at multiple locations on these 
Plasmodium promoter regions over a narrow concentration range. This contrasts strongly the 
highly selective binding of PfTBP in DNAse I footprinting assays reported by the authors. 
In conclusion, there are fundamental differences between the key findings of this MSc research 
project and the results reported by Ruvalcaba-Salazar’s group. These apparent discrepancies 
require further investigation. 
4.4.  Expression and purification of 6His:PfTFIIB:GST
Similarly to PfTBPc expression, IPTG-induction of the recombinant expression of 
6His:PfTFIIB:GST resulted in reduced cell growth compared to uninduced cultures. However, 
6His:PfTFIIB:GST was sufficiently expressed in uninduced cultures for purification and further 
analysis. This is attributed to leaky expression from the IPTG-inducible lacUV5 promoter, that 
drives T7 polymerase expression. Optimal conditions for the uninduced expression of P. 
falciparum proteins were investigated previously by our group and addition of glucose in the 
growth media was found to produce higher cell-density and cell mass, and repress initial leaky 
expression from the lacUV5 promoter. The expression from lacUV5 is regulated by LacI 
repressor and catabolite repression. LacI repressor is active in the absence of lactose and can be 
inactivated by IPTG to induce expression from the lacUV5 promoter. In addition, the expression 
of the lac operon is mediated by catabolite activator protein (CAP) which is naturally expressed 
in E. coli and is inactive in the presence of glucose. Glucose depletion from the media activates 
CAP, allowing for low levels of T7 polymerase expression from the lacUV5 promoter and 
subsequently the expression of PfTFIIB. In conclusion, PfTFIIB expression was achieved by 
auto-induction was set as a standard for further PfTFIIB expression in this study.  
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6His:PfTFIIB:GST was purified using double-affinity chromatography. Interestingly, 
6His:PfTFIIB:GST purified as a doublet band in SDS PAGE, with apparent molecular weights 
of 68 and 70kDa. A similar doublet with the same relative migration of the two bands was later 
seen with 6His-tagged PfTFIIB and PfTFIIB∆37. Both bands of the doublets observed with 
these proteins reacted equally with α-PfTFIIB antibody. However, the C-terminal core domain 
migrated as a single band in SDS PAGE. The PfTFIIB residues 38-82 show high homology to 
other eukaryotic TFIIBs and are predicted to form a zinc-finger (Steven Bing, MSc thesis 2015). 
Zinc-finger-containing proteins migrating as a doublet on SDS PAGE have been reported 
previously (Lindstrom et al., 2014). It is seems plausible that PfTFIIB purifies as a heterogenous 
population with distinct zinc-finger conformations, that are not fully denatured by SDS. Future 
studies, utilising point mutations in structurally crucial residues of the predicted zinc-finger 
could further substantiate these findings.  
4.5.  Expression and purification of 6His-tagged PfTFIIB and PfTFIIB deletion 
mutants 
The expression conditions established by pilot studies with 6His:PfTFIIB:GST were 
subsequently utilised for the large scale expression of 6His:PfTFIIB, 6His:PfTFIIB∆37 and 
6His:PfTFIIB∆140. By utilising the 6His-tag as well as the high pI of all the PfTFIIB variants, a 
standard purification scheme utilising Ni-NTA affinity and ion exchange chromatography was 
established.  
4.6.  PfTBP-independent PfTFIIB DNA-binding activity 
Initial DNA-binding experiments indicated strong PfTBP-independent DNA-binding activity of 
PfTFIIB. In order to determine the PfTFIIB regions with DNA-binding activity, two N-terminal 
deletion mutants were generated, lacking the highly basic N-terminal residues 1-37, or the whole 
N-terminus (residues 1-140) of P. falciparum TFIIB. Subsequent DNA-binding assays revealed a 
number of interesting features of PfTFIIB: (i) C-terminal core domain is sufficient to bind DNA 
in a PFTBP-independent manner and this binding activity is significantly enhanced by the N-
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terminus (ii) Similarly to PfTBP, PfTFIIB DNA-binding activity is increased at a lower 
temperature and resulting complexes are significantly more stable. (iii) Increasing PfTFIIB 
concentrations corresponded to the resulting decrease in the mobility of the PfTFIIB-DNA 
complexes in Mg2+ agarose EMSAs, indicative of PfTFIIB binding at multiple locations on the 
probe. (iv) PfTFIIB DNA-binding affinity is higher for P. falciparum promoter regions or 
generally A/T-rich sequences, in comparison to G/C-rich promoter regions containing a 
consensus TATA-motif. 
In eukaryotes, TFIIB binds to promoter-bound TBP and stabilises the resulting TBP-TFIIB-DNA 
complex via interactions with IIB recognition sequences up- and downstream of the TATA-motif 
(BREu and BREd, respectively; discussed in detail in Chapter 1.2.4). The TFIIB C-terminal 
region interacts with TBP and BREs and has been shown to be sufficient for the formation of 
TBP-TFIIB-DNA ternary complex in crystal structures (Nikolov et al., 1995). The N-terminal 
region of PfTFIIB is involved in the recruitment of RNAPII and TFIIF to the pre-initiation 
complex and DNA-binding activity of this region has not been previously reported. P. 
falciparum TFIIB N-and C-termini contain 37- and 17-residue regions, respectively, that are 
positively charged (pI 11.7 and 10.8, respectively) and absent in human TFIIB. In this MSc 
research, PfTBP-independent DNA-binding activity was first observed in ITAs, where the 
PfTFIIB C-terminal core domain was found to be sufficient to bind to the P. falciparum putative 
kahrp promoter region. The binding of C-terminal domain was further enhanced by the presence 
of minimally residues 38-140 of the N-terminus. Consistent with the ITA findings, the more 
sensitive agarose EMSA experiments indicated that the N-terminal 37-residue basic region of 
PfTFIIB significantly contributes to IIB binding activity. The C-terminal region alone had lower 
DNA-binding activity compared to full length PfTFIIB in Mg2+ agarose EMSAs. In native 
PAGE EMSAs, full length PfTFIIB-DNA complexes could not be detected. High binding 
activity of the N-terminus, potentially due to non-specific binding by the highly charged region, 
could lead to aggregation of the protein-DNA complexes, which cannot be resolved under the 
conditions. Taken together, the results presented in this study suggest that a proportion of DNA-
binding activity of PfTFIIB can be attributed to the charged N- and C-termini, that bind DNA in 
a non-specific manner due to charge attraction. However, considering limited structural 
information on PfTFIIB, specific binding via DNA-binding motifs cannot be excluded.  
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In Mg2+ agarose EMSAs, PfTFIIB formed fast-migrating complexes with DNA that are different 
from the previously observed PfTBP-DNA complexes in many aspects. Firstly, PfTFIIB-DNA 
complexes show decreased mobility in comparison to PfTBP-DNA complex. Secondly, the 
binding activity of PfTFIIB is lower than that of PfTBP and the PfTFIIB-DNA complexes are 
more sensitive to challenges with nonspecific competitor than PfTBP-DNA complexes. Thirdly, 
PfTFIIB binds P. falciparum promoter regions with higher affinity than the model Ad2ML 
promoter, whereas PfTBP binds both promoters with similar affinity. These differences in 
binding affinity, complex stability and mobility collectively suggest different DNA-binding 
characteristics of PfTBP and PfTFIIB.  
The extensive PfTBP-independent binding activity of PfTFIIB reported in this study, has not 
been detected previously in EMSAs with other eukaryotic TFIIBs. Eukaryotic TFIIB binds TBP 
and stabilises the resulting TBP-TFIIB-DNA complex via interactions with BREs. Considering 
this known DNA-binding activity of eukaryotic TFIIB via BREs, it is interesting to speculate if 
the PfTFIIB interactions with DNA observed in this study are akin to the specific interactions 
with BREs observed in other eukaryotes. Eukaryotic TFIIB contacts the upstream IIB 
recognition sequence, BREu, within the DNA major groove, upstream of the TATA-box via 
helix-turn-helix (HTH) motif, a trihelical bundle in the second direct repeat of TFIIB core 
domain (Lagrange et al., 1998, Tsai and Sigler, 2000). TFIIB is known to interact with BREu in 
a TBP-independent manner. However, these interactions were determined by crystallographic 
and photo-crosslinking studies and have not been previously detected in EMSA conditions (see 
Chapter 1.2.4). The downstream IIB recognition sequence, BREd, is distinct from BREu and its 
TBP-dependent interaction with TFIIB is mediated by TFIIB recognition loop within the first 
direct repeat (Deng and Roberts, 2005). Sequence analysis and structural predictions of PfTFIIB 
indicate a notable conservation in the BREd recognition region of the first direct repeat (Steven 
Bing, MSc thesis 2015). However, similarly to plants and fungi (Lagrange et al., 1998), only a 
few basic residues of the HTH motif are conserved in PfTFIIB (Steven Bing, MSc thesis 2015). 
Crystallographic and mutational studies are necessary for any conclusive evidence regarding the 
conservation of function of these binding motifs in P. falciparum TFIIB. BREs are G/C-rich 
sequences (BREu: 5’-G/C-G/C-G/A-C-G-C-C-3’; BREd: 5’︎-G/A-T-T/G/A-T/G-G/ T-T/G-T/
G-3’) and show relatively low conservation within eukaryotes (Gershenzon and Ioshikhes, 
2005). In archaea, despite the presence of the highly conserved HTH motif (Kosa et al., 1997), 
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the BREu sequence has low homology to eukaryotic BREs and is notably A/T-rich (Qureshi and 
Jackson, 1998).  
The A/T-rich P. falciparum promoter regions used in this study do not contain the consensus 
BREd or BREu sequences, whereas the Ad2ML promoter contains both a BREu and a 6/7 match 
to the consensus BREd. However, our preliminary data indicate a higher binding affinity of 
PfTFIIB towards the P. falciparum kahrp promoter than Ad2ML. Given the low homology 
between human and Plasmodium TFIIB and the uniquely A/T-rich genome of P. falciparum, the 
extensive PfTBP-independent DNA-binding could be, at least in part, explained by significant 
alteration of the BRE consensus sequences in P. falciparum and alternative DNA-binding motifs 
of PfTFIIB. 
In native polyacrylamide EMSAs, PfTFIIB∆140 and PfTFIIB∆37 formed distinct complexes 
with 60bp kahrp and var probes. Multiple complexes were seen with the var probe and could 
indicate the presence of multiple binding sites or a conformational change of DNA induced by 
PfTFIIB. To date, there is no evidence for TFIIB-induced DNA-bending in eukaryotic or 
archaeal systems in the absence of TBP. In Mg2+ agarose EMSAs, increasing PfTFIIB 
concentrations further decreased the PfTFIIB-DNA shift, indicating successive binding of 
multiple PfTFIIB molecules, that bind to lower affinity binding sites upon increasing PfTFIIB 
concentrations. Therefore, the multiple complexes seen in native PAGE EMSAs with var probe 
are likely due to multiple PfTFIIB molecules bound to the probe.  
Similarly to PfTBP, PfTFIIB DNA-binding activity was increased at a lower temperature and 
resulting complexes were significantly more stable. The effect of incubation temperature on the 
activity of P. falciparum proteins was first noticed in this study and further assessments within 
our research group have thus far confirmed the preference for lower incubation temperatures 
also with other P. falciparum general transcription factors. The physiological environment of the 
parasite might be highly relevant in these sensitive assays and further studies are needed to 
investigate this possibility.  
Eukaryotic TBP DNA-binding in then absence of TAFs or GTFs is unstable in EMSA 
conditions, however, our results suggest stable PfTBP-DNA complex formation at multiple 
locations. Considering this apparent promiscuity of PfTBP, it is possible, that PfTFIIB has an 
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extensive role in stabilisation of specific PfTBP-DNA complexes through promoter recognition 
via currently undescribed DNA-binding mechanisms and promoter elements. This is an 
interesting possibility that needs to be further investigated by PfTFIIB structural studies and 
binding site selection experiments.  
4.7.  Recruitment of PfTFIIB to promoter DNA by PfTBP
TFIIB plays a fundamental role in the stabilisation of the TBP-DNA complex in eukaryotes. 
Upon TBP binding to the TATA-motif, TFIIB binds beneath the TBP-TATA complex, where 
TFIIB first direct repeat of the core domain contacts TBP via its acidic carboy-terminal stirrup 
(Nikolov et al., 1995). As a result, TBP-TFIIB-promoter ternary complex is formed (Orphanides 
et al., 1996), which is stabilised by TFIIB sequence-specific contacts with BREs. TFIIB 
increases the affinity of TBP for the TATA box (Imbalzano, 1994), whereby the C-terminal 
TFIIB core domain is sufficient for the specific interactions with TBP and TBP-TFIIB-DNA 
complex formation (Nikolov et al., 1995). In this study, we report recruitment of PfTFIIB to the 
promoter by the presence of PfTBP under conditions, where independent PfTFIIB DNA-binding 
is suppressed. In agreement with the current eukaryotic model, PfTFIIB C-terminal core domain 
was found sufficient for the recruitment by PfTBP. We did not observe any significant 
stimulatory effect on PfTBP DNA-binding by the presence of PfTFIIB in immobilised template 
assays. Our findings provide first evidence for interactions between PfTBP and PfTFIIB and 
recruitment of PfTFIIB to promoter DNA by PfTBP.  
4.8.  PfTBP-PfTFIIB-promoter ternary complex formation
 
The stabilisation of promoter-bound TBP by TFIIB is thought to be caused by the combination 
of protein-protein interactions between TBP and TFIIB, and TFIIB interactions with BREs up- 
and downstream of the TATA-box. As a result, TBP-TFIIB-promoter ternary complex with an 
extended sequence specificity is formed ( Imbalzano, 1994, Deng and Roberts, 2007). It has 
been shown that TBP-induced DNA-bending ensures the optimal spatial arrangement for TFIIB 
to access both BREs simultaneously (Lee and Hahn, 1995, Lagrange et al., 1998). Interestingly, 
our results indicate that PfTBP might not induce the degree of DNA-bending observed with 
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other eukaryotic TBPs due to the absence of a crucial Phe residue. The ability of TFIIA and 
TFIIB to recover mutated TBP with impaired DNA binding properties has been reported 
previously, where the addition of TFIIA or TFIIB results in TBP-TFIIA(TFIIB)-DNA complexes 
comparable to those observed with wild-type TBP (Lee et al., 1992, Kim et al., 1994).  
The PfTFIIB and PfTBP orthologues utilised in this study possess strong DNA-binding activity 
in EMSA conditions, in contrast to their eukaryotic counterparts. In order to detect cooperative 
DNA-binding effect or stimulation of PfTBP DNA-binding in the presence of PfTFIIB, the 
independent DNA-binding of both protein factors was completely suppressed with poly(dG-dC). 
Incubation of PfTBP in the presence of PfTFIIB resulted in the formation of a distinct complex 
under these conditions. The mobility of the resulting complex was comparable to that of 
individual PfTBP- and PfTFIIB-DNA complexes. Thus, the observed complex is likely in an 
unbent conformation.  
We tested for the presence of both PfTBP and PfTFIIB in the observed complex using custom-
made polyclonal α-PfTBP and α-PfTFIIB antibodies. Inclusion of antibodies in the binding 
reaction often results in a further decrease of the ternary complex mobility, called a supershift. 
Alternatively, antibodies may inhibit protein-DNA complex formation and/or disrupt protein-
DNA complexes. Indeed, inhibition of complex formation in the presence of specific antibody, 
rather than a supershift, has been observed previously with human TBP-TFIIB-promoter 
complex (Maldonado et al., 1990). Similarly, we observe complete inhibition of PfTBP-
PfTFIIB-promoter complex in the presence of α-PfTBP or  α-PfTFIIB antibodies, but not in the 
presence of equivalent amounts of α-PfTFIIA antibody. This inhibition is likely due to the 
antibodies obstructing PfTBP/PfTFIIB or PfTBP/DNA interaction surfaces. These results 
confirm the presence of both PfTBP and PfTFIIB in the complex. The formation of a novel 
complex with both protein factors present, under conditions where individual PfTBP and 
PfTFIIB DNA-binding is suppressed, provides strong evidence for the formation of a ternary 
PfTBP-PfTFIIB-promoter complex. Considering the novel DNA-binding characteristic of 
PfTFIIB observed in this study and the likely unbent conformation of the ternary complex, it is 
plausible that PfTFIIB stabilises the ternary complex by currently undescribed mechanisms. The 
DNA-binding experiments conducted in this study do not allow to infer the precise mechanism 
of the cooperativity between PfTBP and PfTFIIB. Crystallographic and structural studies are 
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necessary to further characterise PfTBP-PfTFIIB-promoter ternary complex.  
Initial assessment of DNA sequence preference of the ternary complex was carried out with pre-
assembled PfTBP-PfTFIIB-kahrp promoter complexes, that were challenged with unlabelled 
kahrp, gbp-130 or Ad2ML promoter regions. Interestingly, no significant effect was seen with 
excess unlabelled Ad2ML promoter, whereas both P. falciparum putative promoter regions 
efficiently competed with the labelled kahrp promoter for the ternary complex binding. Previous 
experiments with isolated PfTBP indicated similar DNA-binding affinity on P. falciparum and 
Ad2ML promoters, whereas experiments in the presence of PfTFIIB results reveal a clearly 
higher preference of the PfTBP-PfTFIIB-promoter ternary complex for P. falciparum promoters. 
These results are in agreement with the model of extended sequence specificity of TBP-TFIIB-
promoter ternary complex in comparison to TBP-promoter complex (Imbalzano, 1994). 
Therefore, it seems plausible, that PfTFIIB has developed mechanisms for extended  sequence 
recognition in an unbent PfTBP-PfTFIIB-DNA complex. To our knowledge, this is the first 
demonstration of cooperative binding between P. falciparum general transcription factors and the 
formation of PfTBP-PfTFIIB-promoter ternary complex. 
Conclusion 
This MSc research reports the successful expression of PfTBPc and PfTFIIB. Expression vectors 
for wild-type and mutant PfTFIIB were constructed and standard purification scheme was 
established for all P. falciparum proteins used in this study. Initial characterisation of PfTBP and 
PfTFIIB revealed extensive DNA-binding activity of PfTBP and to date undescribed PfTBP- 
independent binding activity of PfTFIIB. Furthermore, to our knowledge, this is the first report 
of PfTBP and PfTFIIB interactions and ternary complex formation. Initial sequence preference 
for A/T-rich sequences was observed, with increased specificity of the ternary complex. This 
study provides an important starting point for the identification of the DNA elements directing 
transcription events in P. falciparum on a path towards understanding the complex gene 
expression regulation in this important parasite. 
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Figure 27. Plasmid map of pET11d-6His-PfTFIIB-GST
Figure 28. Plasmid map of pET11d-6His-PfTFIIB∆37
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Figure 29. Plasmid map of pET11d-6His-PfTFIIB
Figure 30. Plasmid map of pET11d-6His-PfTBPc
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Figure 31. Plasmid map of pET11d-6His-PfTFIIB∆140
APPENDIX B 
 
 
 
Primer 
#
Primer 5’to 3’ sequence RE 
site 
Construction of pET11d-6His-PfTFIIB-GST
1 T7T-FWD 5‘-CACCGCTGAGCAAT AACTAGCATAA-3’
2 EcoRI-REV 5‘-CGTCTTCAAGAATTCTCATGTTTGACA-3’ EcoRI 
3
BamHI-TEV-GST-
FWD 
5‘-TTAAGATCTGGATCCGAAAACCTGTATTTTCAGGGCAT 
GTCCCCTATACTAGGTTATTGGAAA-3’ BamHI
4 T7T-GST-REV 
5‘-TTATGCTAGTTATTGCTC 
AGCGGTGGCAGCAGCCAACCTATTATTTTGGAGGATGGT
CGCCACCA-3’
5
BamHI-TEV-FWD 
(used for overlap 
extension PCR)
5‘-TTAAGATCTGGATCCGAAAACCTGTAT-3’
6
EcoRI-REV 
(used for overlap 
extension PCR)
5‘-CGTCTTCAAGAATTCTCATGTTTGACA-3'
7
PfIIB-FWD 
(used for cDNA 
amplification)
5’-GGCAGCCATATGTCATCCATTTCTCCAAATAAAAAG-3’ NdeI 
8
PfIIB-REV-2 
(used for cDNA 
amplification)
5’-GCAGCCAGATCTGTTTTTTTTCCTGTCTTCACTAAG-3’ BglII 
Construction of pET11d-6His-PfTFIIB; pET11d-6His-PfTFIIB∆37; pET11d-6His-PfTFIIB∆140
9 PfIIB-FWD 5’-GGCAGCCATATGTCATCCATTTCTCCAAATAAAAAG-3’ NdeI 
10 PfIIB-REV 5’-GCAGCCAGATCTCTATTAGTTTTTTTTC CTTTTGTCTTCACTAAG-3’ BglII 
11 PfIIB∆37-FWD 5’- GGCAGCCATATGAATGATCAAACATTA ATTTCCGCATTTAATATC-3' NdeI 
12 PfIIB∆140-FWD 5’- GGCAGCCATATGTTAAGAAACTTTAGGAATAGTAGAAA-3' NdeI 
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